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Abstract
Severe trauma to the limbs can often result in the lesioning, or even amputation, of the underlying peripheral
nerves. In these cases, endogenous neural repair mechanisms are compromised and a path to the end target
may be lost, resulting in the need for surgical intervention. Current repair strategies are incapable of
maintaining this regenerative pathway, or providing a bridge to a surrogate end target, often resulting in
incomplete repair.
This thesis describes the development and evaluation of a novel method of addressing peripheral nerve lesions
and amputations that utilizes living tissue-engineered neural grafts. These grafts are created by the controlled
mechanical separation of axons spanning integrated neuron populations in vitro, resulting in axon tracts
spanning several centimeters in length. Techniques were developed to encapsulate and transplant these tracts,
with the goal of providing structural and nutrient support, while minimizing macrophage infiltration. The
efficacy of these constructs in the treatment of lesions and amputations was then assessed using a rat sciatic
nerve transection model.
In the first study, the ability of neural constructs to (a) encourage host regeneration from the proximal stump,
while also (b) attenuating distal pathway degeneration, was evaluated. At the 4-week time point, the axonal
constructs were observed to promote more robust host axonal and tissue regeneration across the graft when
compared to unstretched grafts. A measurement of nerve conduction velocities also revealed a statistically
significant improvement in the stretch-grown group, correlating with the observed increased fiber
regeneration. At the distal pathway, neural constructs were observed to prevent the atrophy of the support
cells, and maintain the alignment of the Schwann cell columns for up to 4 months. These results suggest that
the use of neural grafts may expand the time window within which successful nerve regeneration can occur.
The axon grafts were then shown to support and maintain regenerating host axon fibers for up to 4 weeks in
the absence of a distal end target. Finally, axon grafts pre-attached to an implantable electrode substrate were
shown to encourage host ingrowth to the vicinity of the substrate, showing promise for the development of a
chronic brain-machine interface.
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ABSTRACT 
EVALUATING THE USE OF ENGINEERED NERVOUS TISSUE CONSTRUCTS 
IN THE REPAIR OF PERIPHERAL NERVE LESIONS AND AMPUTATIONS 
Niranjan Kameswaran 
Douglas H Smith, MD 
 
 Severe trauma to the limbs can often result in the lesioning, or even 
amputation, of the underlying peripheral nerves.  In these cases, endogenous 
neural repair mechanisms are compromised and a path to the end target may be 
lost, resulting in the need for surgical intervention.  Current repair strategies are 
incapable of maintaining this regenerative pathway, or providing a bridge to a 
surrogate end target, often resulting in incomplete repair. 
 This thesis describes the development and evaluation of a novel method 
of addressing peripheral nerve lesions and amputations that utilizes living tissue-
engineered neural grafts.  These grafts are created by the controlled mechanical 
separation of axons spanning integrated neuron populations in vitro, resulting in 
axon tracts spanning several centimeters in length.  Techniques were developed 
to encapsulate and transplant these tracts, with the goal of providing structural 
and nutrient support, while minimizing macrophage infiltration.  The efficacy of 
these constructs in the treatment of lesions and amputations was then assessed 
using a rat sciatic nerve transection model. 
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 In the first study, the ability of neural constructs to (a) encourage host 
regeneration from the proximal stump, while also (b) attenuating distal pathway 
degeneration, was evaluated.  At the 4-week time point, the axonal constructs 
were observed to promote more robust host axonal and tissue regeneration 
across the graft when compared to unstretched grafts.  A measurement of nerve 
conduction velocities also revealed a statistically significant improvement in the 
stretch-grown group, correlating with the observed increased fiber regeneration.  
At the distal pathway, neural constructs were observed to prevent the atrophy of 
the support cells, and maintain the alignment of the Schwann cell columns for up 
to 4 months.  These results suggest that the use of neural grafts may expand the 
time window within which successful nerve regeneration can occur. 
 The axon grafts were then shown to support and maintain regenerating 
host axon fibers for up to 4 weeks in the absence of a distal end target.  Finally, 
axon grafts pre-attached to an implantable electrode substrate were shown to 
encourage host ingrowth to the vicinity of the substrate, showing promise for the 
development of a chronic brain-machine interface. 
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Chapter 1:  Introduction 
 
1.1  Clinical Relevance 
Peripheral nerve (PN) trauma is a serious condition affecting 2.8% of trauma 
patients annually [Chiono V et al, 2009].  This form of injury is primarily caused 
by traumatic accidents, tumor resection or iatrogenic effects of surgeries such as 
orthopedic procedures [Kretschmer T et al, 2001], and can often lead to lifelong 
pain and disability.  Etiologies of PN trauma include penetrating injury, crush and 
ischemia [Robinson LR, 2004].  Upper limb injuries occur in over 70% of reported 
cases, with the ulnar nerve being most frequently damaged.  
Table 1.1 – The Sunderland Classification of Nerve Injury 
Sunderland Scale Description 
First degree Neurapraxia – segmental demyelination 
Second degree Axonotmesis with intact endoneurium 
Third degree Axonotmesis with damaged endoneurium, intact perineurium 
Fourth degree Axonotmesis with damaged perineurium, intact epineurium 
Fifth degree Neurotmesis – disruption of entire nerve trunk 
Campbell WW, 2008 
The Sunderland classification is a widely used scheme for classifying 
peripheral nerve injury [Table 1.1] (Sunderland S, 1990).  According to this scale, 
the mildest form of PN injury is neurapraxia, or segmental demyelination, which 
results in an inability of the nerve to conduct action potentials across the affected 
region.  The loss of function persists until subsequent remyelination, and is 
typically resolved within 12 weeks.  Axonotmesis, which is most often associated 
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with crush injuries, refers to the loss of continuity of the axon wherein the 
ensheathing structures remain at least partially undamaged.  Repair typically 
occurs naturally, and the extent of recovery is thought to be a function of the 
location of the injury and the degree of disruption of the surrounding stroma.  The 
most severe form of PN lesion is neurotmesis.  Here, the entire nerve trunk is 
severed and the ability of the axons to functionally reconnect with their targets is 
severely compromised.  This type of injury typically requires surgical intervention, 
and even minor functional recovery can take several months using current 
treatments [Campbell WW, 2008]. 
The most debilitating form of PN damage occurs as a result of limb 
amputation.  Without presentation of a distal target, the proximal neurites 
frequently undergo extensive collateral branching, resulting in either inaccurate 
innervation of surrounding tissue or the formation of painful neuromas.  Although 
the nerve remains electrophysiologically functional, there currently exists no 
chronic means of recording its activity. 
 
1.2 Hypotheses and Goals 
 By exploiting a newly discovered method of creating axonal tracts in vitro 
using mechanical tension, we have been able to create transplantable nerve 
constructs that can be used to repair damaged axonal tracts and nerves.  In the 
following studies, the applicability of these nerve grafts in the repair of PNS 
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lesions and amputations is assessed.  The study design was motivated by the 
following hypotheses: (1) neural constructs can provide regenerative support for 
the proximal stump while attenuating degeneration of the distal pathway, and (2) 
living axonal constructs can provide support for the extension and maintenance 
of regenerating neurites in the absence of a distal target. 
In chapter 2, a synopsis of the stretch-growth mechanism and its 
adaptability for various therapeutic applications is provided.  Chapter 3 describes 
the development of techniques to encapsulate and transplant nervous tissue 
constructs into a rat sciatic nerve lesion.  Chapter 4 illustrates the beneficial 
effects of using these constructs for (a) repairing a short nerve lesion, and (b) 
maintaining the support architecture at the distal stump, potentially increasing the 
window for successful target reinnervation.  Finally, chapter 5 describes how 
these axonal constructs can be used to (a) extend and maintain regenerating 
proximal axons in the absence of a distal target, and (b) encourage host axonal 
growth towards an electrode substrate, which may ultimately enable bi-directional 
communication with the peripheral nervous system. A synthesis of these findings 
is provided in chapter 6, as well as future work for this field of study.   
  5 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Chapter 2:  Overview of Stretch-induced Axonal Growth 
 
 
The study of axon growth has traditionally comprised two distinct areas – 
growth cone extension and guidance during embryogenesis, and nerve 
regeneration following traumatic injury.  In both these cases, the axon has a free 
end that advances towards its final target using chemotaxic and/or haptotaxic 
cues.  However, we now know that there is a third form of axon growth that 
occurs after synaptic integration with the target, and is triggered by the 
application of mechanical tension.   This form of growth, which we dub “stretch-
growth”, is a newly discovered phenomenon that challenges long-held notions on 
axonal transport and protein assembly, and could potentially transform our 
understanding of post-embryonic nerve development. 
 
Traditional concepts on axon growth 
Growth cone motility and axonal pathfinding during embryonic 
development has been extensively studied over the years [Dickson, 2002; Yu 
and Bargmann, 2001; Tessier-Lavigne and Goodman, 1996].  During this 
process, pioneer axons forge the initial path to the target, following which all 
other axons advance.  The pioneer axons are influenced by the push-pull effect 
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of attractive and repulsive chemotaxic cues in the surrounding milieu, as well as 
the internal mechanical forces generated at the tip of the growth cone.  Trailing 
axons, on the other hand, are believed to respond to a combination of these 
chemotaxic cues and contact-influenced guidance.  Protein assembly has been 
shown to occur within the growing tip.  Developing axons grow at a rate of 
approximately 1mm/day, and this phase of neurogenesis is typically complete 
within 8 weeks in humans. 
The other form of axon growth that has been extensively researched is 
post-trauma regeneration.  Here, the proximal segment of a transected axon 
attempts to rejoin its target by a process remarkably similar to that seen during 
development.  After injury, the neuron shifts from a transmitting mode to a growth 
mode resulting in a growth cone lamelipodial formation at the tip (Dahlin, 2006).  
This growth cone is guided across the lesion primarily via chemoattractive and 
chemorepulsive cues until it reaches the distal support cells, after which the 
guidance is primarily contact-mediated (Mueller, 1999; Goodman, 1996).  The 
response to injury can begin within hours of the insult and may persist for as long 
as 12 months [Campbell WW, 2008]. 
While both of these forms of axonal outgrowth are essential for the 
formation and maintenance of the nervous system, neither can account for the 
rapid growth of already-integrated axonal tracts in the fetus and thereafter.  Since 
the axons no longer having growing tips, the rapid expansion must occur by a 
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completely different mechanism, a process of stretch-growth that we are only 
now beginning to understand. 
 
Stretch-growth – a newly discovered form of axonal growth 
The use of mechanical tension to extend the tip of an axon was first 
demonstrated in 1984, where a movable substrate was used to tow chick 
sensory ganglion growth cones [Bray, 1984].  This work has expanded upon 
since, to induce transient lengthening of the growth cones of single axons in vitro 
[Dennerll et al., 1989; Zheng et al., 1991; Heidemann et al., 1995; Chada et al., 
1997].  The interpretation of these findings was that tension generated at the 
growth cone (by internal cytoplasmic components) is a key factor for the growth 
of axons.  However, the idea that external mechanical forces may play a role in 
the growth of synaptically-integrated axon tracts was suggested as far back as 
1935 by RG Harrison and 1941 by Paul Weiss, who referred to it as “passive 
stretching” and “towing” respectively.  They noted that at the peak growth of the 
human fetus, motor axons in the lower limb grow at rates approaching 
1.2mm/day, which is well within the known rates of axonal transport.  However, 
evidence of far more rapid axonal growth can be seen elsewhere in nature.  Axon 
tracts in the giraffe neck have a peak growth rate of 2cm/day [Bannister et al, 
1996; Dagg and Foster, 1982].  Axon tracts in the blue whale spine are estimated 
to grow at even more astonishing rates, potentially exceeding 3cm/day [Smith 
DH, 2009].  These observations challenge fundamental notions of neural protein 
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synthesis and transport.  The rate of axonal growth has traditionally been thought 
to be limited by slow transport – indeed, neurofilament proteins have been shown 
to be shipped down the axon at the rate of a few millimeters per day [Brown, 
2003; Nixon, 1998a,b; Roy et al, 2000], which is well below the rates described 
here.  Even at fast transport rates of 300mm/day, it would take over three months 
for neurofilament proteins to be carried the 30m distance from the cell body down 
the length of a blue whale axon [Smith DH, 2009].  A possible explanation for this 
discrepancy could be local synthesis of protein within the axon itself [Alvarez J et 
al 2000; Brittis PA et al, 2002], which would preclude the need for such long-
distance transport. 
 
Experimental verification of stretch-growth using rat primary cortical neurons 
  The development of techniques to create transplantable stretch-grown 
axon tracts evolved from in vitro experiments examining traumatic axonal injury 
[Wolf et al, 2001] using rat primary cortical neurons.  In these experiments, 
tension was transiently applied to axons spanning two neural populations 
spanning a short gap with the goal of producing a deleterious effect.  However, it 
was noticed that the axons demonstrated a resilience to stretch at less rapid 
strain rates.  Expanding upon these findings, an in vitro stretch-growth model 
was developed wherein axons spanning two populations of either cortical or N-
tera 2 cell line neurons were allowed to integrate over several days and then 
were slowly separated using a micro-stepper motor (Figure 2.1).  In initial 
  10 
studies, the populations were separated at the rate of 3.5µm every 5 minutes, 
resulting in 1cm axon tracts after 10 days of stretch-growth (Figure 2.2, left).  The 
axons were also seen to coalesce into highly organized fascicles (Figure 2.2, 
right), potentially replicating the mechanism of organized axonal tract formation 
during development [Smith et al, 2001]. 
 
 
 
 
 
Figure 2.1:  Axon stretch‐growth device.  Integrated axon tracts in the stretching frame are mechanically separated in a controlled manner by the computer‐controlled micro‐stepper motor system. 
  11 
2.1.4 Extreme stretch-growth of rat dorsal root ganglion axons 
 With a view towards development of a transplantable axonal construct for 
eventual clinical usage, dorsal root ganglia (DRG) neurons were selected as our 
primary cell source.  Adult human DRG neurons can be harvested from patients 
undergoing elective ganglionectomies, making them a viable autologous cell 
source.  Human and animal DRG neurons are also known to be robust in culture, 
and can survive for extended periods of time while maintaining normal 
electrophysiological function [Pfister et al, 2006a,b]. 
Subsequent experiments revealed strain rate and acclimation to be the 
main determining factors for successful stretch-growth.  Starting at the low rate of 
1mm/day, the strain rate could be gradually increased, provided the axons were 
given a sufficient “rest period” in order to acclimate (Figure 2.3a).  By employing 
Figure 2.2:  Left – The stretch growth of cortical axon tracts as seen at 2, 
4 and 7 days.  Adjacent fibers gradually coalesce into aligned axon 
bundles.  Right – Confocal image of cortical axon bundles after 7 days of 
stretch-growth. 
Smith DH et al, 2001 
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this strategy, growth rates of up to 1cm/day were reached within a few days of 
commencing stretch-growth [Pfister et al 2004].  In addition, integrated axonal 
tracts of up to 10cm length could be created in less than 2 weeks (5cm length 
shown in Figure 2.3b). 
Despite these high-growth rates, the stretch-grown axons were seen to 
possess a normal morphology.  However, the average diameter of these axons 
was measured to be 30% greater than non-stretched DRG axons, possibly in 
order to sustain increased stability and transport.  Transmission electron 
microscopy revealed a normal complement of microtubules and neurofilaments 
per cross-section area.  In addition, the axons were shown to be able to conduct 
Figure 2.3:  Left – Graphical representation of acceptable stretch-growth 
parameters for DRG neurons.  Right – DRG axon tracts in culture spanning 
5cm. 
  13 
normal action potentials, although they did appear to possess an increased 
density of sodium and potassium channels [Pfister et al, 2006a,b]. 
 
  
Using stretch-grown axon tracts to repair the nervous system 
 In addition to providing insight into the mechanisms of axon growth during 
development, stretch-grown axonal constructs may be exploited for nerve repair.  
Living nerve tracts can be rapidly created to any desired length in vitro and 
transplanted to bridge even extensive central and peripheral nervous system 
lesions.  In the case of spinal cord repair, transplanted axonal tracts were used to 
bridge a 1cm defect spanning three vertebrae in the rat.  The constructs were 
seen to survive and remain structurally intact one month post-transplantation 
Figure 2.4:  Survival of transplanted stretch-grown axons in 
the spinal cord at 1 month.  The transplanted cells (indicated 
by the arrows) were found sandwiched between layers of 
collagen in the SCI cavity. 
Iwata A et al, 2006 
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(Figure 2.4) [Iwata A et al, 2006].  Evidence of host axon penetration into the 
graft area, as well as graft neurite outgrowth into the host tissue, was also 
observed.  It is still unclear whether the constructs form functional synaptic 
connections with the host – however, these results demonstrate the feasibility of 
this approach and merit further investigation.   
 
 
 Axonal constructs have also been used to bridge 1cm lesions in the rat 
sciatic nerve (Figure 2.5).  The graft tissue was seen to survive for at least 4 
months without immunosuppression.  Robust intermingling of host and graft 
axons was seen in the repaired lesion area as well as in the proximal and distal 
nerve segments, indicating graft neurite outgrowth into the host.  Analysis of 
Figure 2.5:  Left – Transplanted stretch-grown axonal construct used in 
the repair of a PNS lesion.  The constructs were seen to survive over 
several weeks in vivo, and robust intermingling of host (red) and graft  
(yellow) axons could be clearly seen.  Right – A transverse section of 
the graft revealing axons (green) encircled by myelin sheaths (red). 
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cross-sections of these nerve segments revealed robust regeneration and 
myelination of the axons. 
  
 
 
Stretch-grown axons from Human dorsal root ganglia 
Ultimately in order to be clinically viable, axonal constructs will need to be 
generated from autologous tissue.  As previously mentioned, human DRG 
neurons can be isolated from patients undergoing elective ganglionectomy 
procedures, and can be successfully maintained in vitro.  We have been able to 
obtain ganglia from live human patients, as well as from organ donors, and have 
maintained the tissue in culture for at least 3 months, replicating the findings of 
other studies.  We have also been able to create stretch-grown axonal constructs 
from these human DRGs, thus demonstrating the feasibility of this approach 
[Huang J et al, 2008]. 
 
  16 
 
 
Figure 2.6:  Fluorescence micrographs of adult human DRG neurons 
and axons.  The human DRG neurons were labeled using (A) CGRP or 
neurofilament proteins; (B) RMO-254; (C) SMI-31; and (D) 
neurofilament-200.  Bottom – Aligned fascicles seen upon stretch-
growth of human DRG axons. 
Huang J et al, 2008 
  17 
 
 
 
 
Chapter 3 
 Development of Nervous Tissue Encapsulation Techniques 
  18 
Chapter 3:  Development of Nervous Tissue 
Encapsulation Techniques 
 
With the goal of creating transplantable axonal tracts that may be used to 
bridge CNS and PNS lesions, we have developed techniques to encapsulate and 
remove the constructs from the in vitro environment without disrupting their 
structural integrity and alignment.  The two major components required for 
transplantation are an embedding hydrogel and an encapsulating nerve guidance 
channel.  The primary criteria behind hydrogel selection were structural support 
offered, ability to incorporate nutrient supply and permissiveness to neurite 
outgrowth.  While our initial design solely consisted of a simple collagen 
hydrogel, it has since evolved to include a variety of materials, each serving a 
unique and critical purpose. 
 
Initial design – collagen hydrogel 
 
  The first material employed for construct encapsulation and 
removal was a simple collagen hydrogel (3.67mg/mL) in Dulbecco’s modified 
Eagle’s medium supplemented with nerve growth factor (2.5S, 10ng/mL).  The 
collagen matrix was gently applied over the construct axons and allowed to 
polymerize in the incubator at 37°C.  Upon gelation (typically 10-15 minutes) the 
cell cultures lift off the underlying Aclar membranes and become completely 
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immersed in the collagen.  The embedded axons are then rolled along the axis of 
the tracts, and the entire hydrogel-tissue combination is deposited into a nerve 
guidance channel cut open lengthwise [Iwata et al, 2006]. 
 This approach has several disadvantages.  While the 80% collagen 
does provide a permissive environment for neurite growth and is seeded with 
growth factors, the structural support offered for the axons is minimal.  Removal 
from the culture environment using this technique can be precarious – axon 
tracts are regularly damaged and discarded during the removal process, and 
there is no certain way of determining if they are intact even upon successful 
transference into the tube. With the goal of overcoming these limitations, and 
facilitating easier removal from the culture environment, a variety of additional 
hydrogel components were systematically evaluated. 
 
Incorporation of agarose hydrogel 
 
 Agarose is a naturally occurring polysaccharide that has been extensively 
studied in PNS repair.  It can be easily formulated to a wide range of stiffnesses, 
each of which has different effects on neurite outgrowth.  Neither central nor 
peripheral neurons have any known receptors that interact with agarose side 
chains. 
 Our first goal was to evaluate the range of gel stiffnesses that could be 
applicable to the construct encapsulation and transfer procedure.  It has been 
shown by other groups [Balgude AP et al, 2000] that DRG neurite outgrowth is 
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inversely proportional to the stiffness of the gel used, with minimal outgrowth at 
formulations exceeding 2% (wt/vol).  Our initial design assessment, therefore, 
was limited to agarose formulations of 0.5-2.0% (wt/vol). 
 
 
3.1 Materials and Methods: 
 
Agarose is water-soluble at temperatures exceeding 65°C and typically 
gels at a temperature range of 17-35°C.  It is clear and stable once gelled, and 
does not re-liquefy until heated above 65°C again.  The agarose gels used in this 
experiment were created in the range of 0.5% to 2.0% (0.25% increments, wt/vol) 
by heating and stirring agarose powder (Ultrapure; Invitrogen, Carlsbad, CA) in 
pH 7.4 1x Dulbecco’s phosphate buffered saline (PBS; Gibco, Grand Island, NY). 
Dorsal root ganglion neurons were isolated from embryonic day 15 fetuses 
from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA) rats.  The 
DRG explants were suspended at 5x106 cells/mL in Neurobasal® medium 
supplemented with 2% B-27, 0.4 mM L-glutamine, 1% penicillin/streptomycin, 2 
mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10 ng/mL 2.5S nerve growth 
factor (NGF) and 1% fetal bovine serum (FBS) (HyClone, Logan, UT), and a 
mitotic inhibitor formulation of 10 mM 5-fluoro-2’-deoxyuridine (FdU) (Sigma-
Aldrich), and 10 mM uridine (Sigma-Aldrich) to encourage non-neuronal cell 
elimination. 
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3.2 Results 
 
Evaluation of agarose as an encapsulating medium 
The isolated DRG explants were initially plated at the interface of two 
overlapping membranes of Aclar pre-coated with rat-tail collagen (3.67mg/mL) in 
order to approximate initial stretch-growth conditions.  After allowing the 
populations to integrate over 5 days, liquefied agarose formulations at 37°C were 
added directly over the cultures and allowed to gel by cooling them to 4°C for 2 
minutes, followed by placing them for 10 minutes in the incubator at 37°C.  Using 
a cell scraper, the agarose was then gently separated from the underlying Aclar 
layers.  At all formulations exceeding 1.5%, the cells remained preferentially 
adhered to the underlying collagen substrate and did not separate from the Aclar.  
Below 1%, however, the agarose was structurally fragile and transference into 
the tube repeatedly resulted in fragmentation of the gel and disconnection of the 
integrated axonal connections.  Those instances of successful transfer also 
necessitated the length-wise opening of the tubes for insertion and its 
subsequent re-suturing.  For these reasons the strategy of adding agarose to 
already integrated tracts was abandoned, and its use as an underlying substrate 
was evaluated. 
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Evaluation of agarose as a base substrate 
 In the next design iteration, agarose was used as the base substrate on 
which the cells were directly plated.  Following from our previous findings, the 
formulations were now limited to 1.0-1.5%.  Liquefied agarose was added to the 
bottom Aclar substrate in the elongator chamber, and allowed to gel by cooling it 
to 4°C for 2 minutes followed by 10 minutes in the incubator at 37°C.  The towing 
membrane was then placed over the agarose a thin layer of collagen 
(3.67mg/mL) was then coated over the interface and allowed to polymerize in the 
incubator overnight.  Isolated DRG explants were then added at the interface and 
Figure 3.1:  Stretch-growth of axons spanning two DRG explants plated 
on a 1.25% agarose hydrogel base layer.  Scale bar = 1mm 
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allowed to adhere and integrate over 5 days.  In all 3 formulations (1%, 1.25% 
and 1.5% wt/vol) axons were seen to span the two populations (Figure 3.1).  In 
order to assess ease of removal from the culture environment, matched 
concentrations of agarose were added to the neural populations and the towing 
membranes were gently separated using a cell scraper.  The neurons were found 
to remain encapsulated within the hydrogel, and axon tracts could be easily cut 
out using a scalpel blade and directly inserted into the tube through the open 
ends. 
 
Adaptation of design to incorporate polyimide electrode array 
Figure 3.2:  Axons spanning the interface of a polyimide electrode array and 
the 1,25% wt/vol agarose hydrogel base layer. 
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 A polyimide electrode array was then incorporated into the design, in 
order to develop the optimal parameters for neural-interface encapsulation.  After 
formation of an initial agarose base layer and placement of the towing 
membrane, a thin (1.5mm x 5mm) strip of polyimide was positioned length-wise 
over the agarose at the hydrogel-towing membrane interface.  A thin layer of 
collagen (3.67mg/mL) was added at the towing membrane-polyimide junction, 
and more agarose was added to the other end of the polyimide strip to anchor it 
in place.  As before, isolated DRG neurons were then plated at the interface, and 
allowed to integrate over 5 days (Figure 3.2).   
During encapsulation and removal from the elongation device, it was 
found that the 1% agarose was unable to sufficiently secure the polyimide in 
place, resulting in frequent defragmentation of the encapsulated construct during 
removal and insertion into the tube.  On the other hand, the 1.25% and 1.5% 
agarose formulations did not suffer from this structural disintegration.  As a result 
of these findings, and with the goal of minimizing the agarose stiffness, a final 
agarose concentration of 1.25% wt/vol was selected. 
 
In vivo evaluation of encapsulation design 
In order to assess the feasibility of this design in vivo, static neural 
constructs were generated, encapsulated in 1.25% agarose, inserted into a 1cm 
NeuragenTM tube and sutured to the proximal and distal stumps of a transected 
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sciatic nerve.  The constructs were harvested at 2 weeks and examined for signs 
of nerve regeneration, vascularization and/or host immune response. The 
agarose was still predominantly intact at this time.  Axon infiltration into the tube 
was observed, as were signs of vascular ingrowth (Figure 3.3).  In addition 
however, ED-1 staining revealed substantial macrophage infiltration into the tube 
Figure 3.3:  Confocal reconstructions of the regenerating sciatic nerve (GFP+) 
within the transplanted construct.  (A-B) Axon tracts running longitudinally 
along the nerve.  (C-D) Revascularization was observed along the outer nerve 
perimeter. Scale bars = 50µm 
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(Figure 3.4), and in the general vicinity of the transplanted neurons.  While 
macrophages are a necessary element in the degradation of agarose, their 
infiltration was perceived to be potentially disadvantageous considering the 
presence of the allograft tissue.   
 
 
Final encapsulation design 
 With the goal of attenuating macrophage infiltration, salmon fibrin gel 
(5mg/ml fibrinogen, 5 NIH units/ml thrombin in Neurobasal) was incorporated into 
the final encapsulation design (Figure 3.5).  Salmon fibrin has been shown to 
degrade more slowly than mammalian fibrin, and is resistive to glial and 
Figure 3.4:  ED-1 positive cells adjacent to transplanted DRG 
neurons, indicating macrophage infiltration.  Scale bar = 50µm 
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macrophagic infiltration [Ju Y et al, 2007; Georges PC et al, 2006].  Fibrin is also 
extensively used as a surgical adhesive, thus making it a clinically appropriate 
choice of end sealant. 
Figure 3.5:  Schematic representing final construct encapsulation design.  
The stretch-grown axons, pre-attached to a polyimide electrode array, are 
encapsulated in 1.25% agarose hydrogel and inserted into a NeuragenTM 
nerve guide.  After suturing the tube to the proximal stump, the ends are 
sealed using fibrin gel. 
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3.3 Conclusion 
By exploiting the mechanism of axonal growth, we have been able to 
engineer living axonal tracts of several centimeter lengths in vitro.  We have 
demonstrated our ability to utilize these constructs to repair lesions in the central 
and peripheral nervous system.  By optimizing the encapsulation techniques, we 
have been able to create a stable method of removing the axonal tracts from the 
culture environment without disrupting their alignment and structural integrity.  
This encapsulation design also permits the incorporation of a thin flexible 
electrode substrate for the goal of creating a stable neural interface with the 
peripheral nervous system.  
  29 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Chapter 4:  Repair of Lesions in the Peripheral Nervous 
System Using Stretch-Grown Axonal Constructs 
 
4.1 Overview 
The current ‘gold standard’ for repair of PN lesions are autologous nerve 
grafts.  These grafts, typically of the sural nerve, provide a physical bridge across 
the lesion and supply endogenous biological cues to guide regenerating axons 
from the proximal nerve stump to the remaining distal nerve segment.  However, 
this approach is plagued by permanent loss of harvested nerve function and the 
potential formation of painful neuromas [Lundborg, 2004; Sinis et al, 2007].  
Furthermore, there are obvious limitations in the supply of donor nerves, making 
autografts inadequate to repair extensive nerve damage.  Alternative clinical 
approaches to bridge PN lesions include synthetic tubes composed of 
poly(glycolic acid) (PGA) or collagen; however, these conduits by themselves 
have been only used for bridging relatively small peripheral nerve (PN) gaps 
(Dellon, 2006; Trumble et al., 2006).  Moreover, no current strategy 
simultaneously addresses the steady degeneration of support cells in the nerve 
segment distal to the injury site.  This degeneration ultimately severely limits 
recovery of function due to the eventual loss of cues to guide regenerating axons 
beyond the lesion to their final targets.  This need is particularly important in 
cases of major nerve lesions where lost nerve segments reach greater than 
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several centimeters, or complex lesions to multiple nerves where conventional 
approaches are overwhelmed or unsuitable.  In these instances, the rate of 
regeneration, ranging between 1-4 mm/day, may result in repair taking months or 
even greater than one year, depending on the location of the injury, over which 
time the distal support cells no longer remain.  In addition, the end targets 
themselves will undergo degeneration and atrophy after a period of denervation, 
further impeding functional recovery [Lien SC et al, 2008]. Thus, there is clearly a 
need to address the issue of distal pathway degeneration in conjunction with 
regeneration of the proximal stump in order to enable complete functional 
recovery. 
More recently, tissue-engineered solutions have been sought to overcome 
the limitations associated with autografts and nerve guidance channels. These 
approaches include creating combinations of permissive scaffolds (such as 
decellularized grafts or hydrogels), extracellular matrix  (ECM), trophic factors, 
and glial or stem cells (Evans et al., 2002; Frerichs et al., 2002; Lee et al., 2003; 
Yu and Bellamkonda, 2003; Fansa and Keilhoff, 2004; Hu et al., 2005; Stang et 
al., 2005; Chalfoun et al., 2006; Keilhoff et al., 2006; Nie et al., 2007).  The 
importance of anisotropy has been well recognized as an important spatial cue to 
direct axon growth, and is typically achieved via gradients (e.g., neurotrophic or 
ECM), longitudinally-aligned fibers, or tailored porosity (Matsumoto et al., 2000; 
Bellamkonda, 2006; Dodla and Bellamkonda, 2006; Bozkurt et al., 2007).  
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Typically, the optimization of these tissue-engineered constructs in vitro focuses 
on developing permissive environments for axonal growth cone extension. 
Unfortunately, these approaches typically ignore the fact that axonal 
outgrowth in vivo occurs along Schwann cells and the basal lamina; thus, 
strategies that were optimized based on directly promoting axonal outgrowth in 
vitro may not translate mechanistically.  In addition, all of these approaches are 
geared towards promoting regeneration of the proximal stump; none of these 
strategies can delay the eventual degeneration of the distal pathway. 
We have recently begun investigating axon-mediated axon outgrowth as 
an alterative mechanism of regeneration.  By exploiting the newfound 
mechanism of “stretch-growth”, whereby large axon tracts can be created by the 
controlled and continuous separation of integrated neural populations, we have 
created transplantable neural constructs that have been shown to effectively 
bridge a 1cm sciatic nerve lesion in the rat 4 months post-transplantation. 
However, the advantage of utilizing stretch-grown axonal constructs vis-à-vis a 
simple (or “static”) neural culture was unknown. We also observed evidence of 
graft axon outgrowth into the host nerve; this suggests the possibility of 
maintaining the distal pathway support architecture by providing a temporary 
axonal surrogate, a phenomenon often referred to as nerve “babysitting”. 
Therefore, the objectives of this study were to (1) determine if stretch-grown 
axons provide an advantage over static cultures in promoting of host 
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regeneration, and (2) assess whether axons emerging from the graft can 
attenuate the degeneration of the distal nerve segment. 
 
4.2 Repair of a 1cm PNS lesion using stretch-grown axons 
4.2.1 Relevant Background 
During development of the peripheral nervous system, axons known as 
“pioneer axons” prescribe the initial path for subsequent axons to follow in a 
process known as “selective fasciculation” [Dickson, 2002; Yu and Bargmann, 
2001; Tessier-Lavigne and Goodman, 1996].  The pioneer axons are believed to 
enable this targeted axonal outgrowth by a combination of neurotrophic support 
and contact guidance.  This phenomenon has inspired a variety of strategies in 
the area of peripheral nerve repair.  Several groups are investigating the use of 
growth factors and/or Schwann and glial cell combinations to enhance nerve 
growth within nerve guidance channels [Evans et al., 2002; Frerichs et al., 2002; 
Lee et al., 2003; Yu and Bellamkonda, 2003; Fansa and Keilhoff, 2004; Hu et al., 
2005; Stang et al., 2005; Chalfoun et al., 2006; Keilhoff et al., 2006; Nie et al., 
2007].  Yet others have shown that axons appear to prefer longitudinally-aligned 
fibers [Kim et al, 2008; Bellamkonda, 2006] as a regenerative substrate, and 
attempts are being made to create trophic factor-eluting versions of these [Cao et 
al, 2009]. 
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Building upon these findings, we hypothesize that the axonal portions of 
the tissue-engineered neural constructs contribute more to host PN regeneration 
than static cultures, as they may provide both trophic support, as well as a 
longitudinally aligned pre-established pathway that spans the entire lesion.  In 
this study, we investigate the repair of a 1cm sciatic nerve lesion using 
transplants of stretch-grown axonal constructs as well as static neural (dorsal 
root ganglion) cultures.   
 
4.2.2 Materials and Methods 
 
Overview of Study Design 
 Building upon our previous findings on host nerve regeneration at 6 weeks 
and 4 months [Huang J et al, 2009], the initial study design required harvesting 
the nerve at the 2-week and 4-week time points in order to assess the 
progression of the nerve through the graft.  However, an assessment of host 
regeneration at 2 weeks revealed similar results to the 4-week findings.  This can 
be attributed to the early time point – within days of repair, the proximal nerve 
stump will undergo rapid regeneration and abundant collateral sprouting, both of 
which will be maintained for several weeks to months.  As a result of these 
preliminary observations, the 2-week time point was subsequently discontinued. 
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 At 4-weeks post-transplantation, the nerves were re-exposed for 
electrophysiological evaluation and then immediately harvested for 
immunohistochemistry.  This time-point was selected since the host nerve would 
have regenerated through the length of the transplant, allowing us to compare 
the extent (number of axons) and quality (nerve conduction velocity and latency) 
of the repair. 
 
Dorsal root ganglion neuron isolation 
Dorsal root ganglion (DRG) neurons were isolated from embryonic day 15 
fetuses from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA) 
rats.  The DRG explants were suspended at 5x106 cells/mL in Neurobasal® 
medium supplemented with 2% B-27, 0.4 mM L-glutamine, 1% 
penicillin/streptomycin, 2 mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10 
ng/mL 2.5S nerve growth factor (NGF) and 1% fetal bovine serum (FBS) 
(HyClone, Logan, UT), and a mitotic inhibitor formulation of 10 mM 5-fluoro-2’-
deoxyuridine (FdU) (Sigma-Aldrich), and 10 mM uridine (Sigma-Aldrich) to 
encourage non-neuronal cell elimination.   
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Static Nervous Tissue Constructs 
 
Figure 4.1:  Schematic representation of the bridging of a 1cm sciatic nerve lesion using static DRG neuron cultures 
 
The explants were plated into a collagen-filled (rat tail type 1, 3.67mg/mL) 
agarose (1.25% in 1X PBS; Ultrapure, Invitrogen, Carlsbad, CA) trough 
measuring 2mm x 1cm.  The cell cultures were allowed to form axonal 
connections over 12 days in vitro.  The neural growth medium described above 
was replaced on post-isolation days 1, 3, 5 and 12. 
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Stretch-grown Nervous Tissue Constructs 
 
Figure 4.2:  Schematic representation of the bridging of a 1cm sciatic nerve lesion using stretch‐grown axons 
 
The explants were plated into mechanical elongation chambers custom-
fabricated for the stretch-growth procedure.  The neurons were plated in two 
populations along the interface of a collagen-coated (rat tail type 1, 3.67mg/mL) 
  38 
aclar “towing” membrane and a base layer of agarose (1.25% in 1X PBS; 
Ultrapure, Invitrogen, Carlsbad, CA), resulting in a separation of 50-100µm.  Over 
5 days in vitro, axonal connections were formed between these two populations.  
The populations were then gradually separated over the course of 7 days using a 
stepper motor system until the axons spanning them reach a length of 1cm. 
 
Neural Construct Encapsulation 
On post-isolation day 12, the neural cultures (both static and stretch-
grown) were removed from the incubation chambers and embedded in a 
collagen-based matrix (3.0 mg/mL) in Dulbecco’s modified Eagle’s medium 
supplemented with NGF (2.5S, 10 ng/mL).  After gelation at 37°C, embedded 
cultures were gently removed and placed within a 1cm absorbable collagen 
nerve guidance channel (3mm inner diameter, NeuraGenTM, Integra LifeSciences 
Corp, Plainsboro, NJ). 
 
 
Peripheral Nerve Surgery and Tissue Construct Implantation 
Stretch-grown (n=10) as well as static (n=8) constructs were implanted 
into GFP+ rats (adult male, 400-450mg, strain TgN(act-EGFP)OsbCZ-004).  The 
animals were anesthetized with sodium pentobarbital (Nembutal, 50 mg/kg, i.p.) 
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prior to surgery.  A longitudinal skin incision was made in the hind leg from the 
sciatic notch proximally to the region of the popliteal fossa distally.  The gluteal 
muscle was freed up to expose the sciatic nerve and its posterior tibial branch.  A 
1cm segment of sciatic nerve was transected immediately proximal to the 
trifurcation.  The proximal and distal stumps were carefully inserted into the ends 
of the NeuraGenTM tube with an overlap of 1mm, and the epineurium was 
secured to the tube using 8-0 absorbable sutures.  The ends of the tube were 
sealed with salmon fibrin (5mg/ml fibrinogen, 5 NIH units/ml thrombin) to provide 
additional stability, and to attenuate macrophage infiltration into the tube.  Finally, 
the muscle and skin layers were sutured over the graft with absorbable chromic 
gut 4-0 sutures. 
 
Nerve Electrophysiology 
The sciatic nerve was re-exposed and 4 weeks (n=6) using the 
aforementioned procedure.  The animal was placed on a heating pad to maintain 
body temperature at 37°C.  A stimulating electrode was placed 2mm proximal to 
the transection site, and the recording cuff was placed 2mm distal to the graft.  
All recordings were obtained at a sampling frequency of 4000 samples/s for 20s 
(MP-150; Biopac Systems Inc, Goleta, CA). Stimulation was provided using a 
50µA, 100µs, constant current pulse train (SIU-91A; Cygnus Technology, 
Delaware Water Gap, PA); the current pulse train was controlled by a gating 
command from the recording unit in order to accurately calculate the conduction 
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velocity.  The procedure was repeated on the contralateral side for each animal, 
and the ratio of conduction velocity of the operated side to the non-operated 
nerve was determined.  All related data analyses were performed using standard 
software (Acknowledge 3.9.1; Biopac Systems Inc, Goleta, CA). 
 
Nerve Harvest and Histological Analyses  
Immediately following electrophysiological evaluation, the constructs were 
harvested by transecting the nerve 2mm proximal and 2mm distal to the graft 
(Figure 4.3), and were placed in 4% paraformaldehyde.  The animals were 
euthanized by an overdose of sodium pentobarbital. 
Figure 4.3:  The grafted neural construct (indicated by the 
arrow) being harvested at the 4-week time point.   The 
collagen tube can be seen to be securely fastened to the 
proximal (left) and the distal (right) nerve segments.  Note 
the negligible fibrotic response around the tube. 
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Following overnight fixation in paraformaldehyde, the excised tissue was 
removed and immersed in 30% sucrose solution.  The tissue was then 
cryosectioned longitudinally (15-25µm), and immunostained for (i) neurofilament-
200kDa (NF-200; N0142, 1:200; Sigma-Aldrich), (ii) myelin basic protein (MBP; 
SMI-94R, 1:500, Covance Research Products, Princeton, NJ), (iii) S-100 (1:500; 
Dako, Carpinteria, CA), or (iv) calcitonin gene-related peptide (CGRP; C8198, 
1:1000 Sigma-Aldrich). The appropriate secondary fluorophore-conjugated 
antibodies (TRITC- or AMCA-conjugated IgG; Jackson ImmunoResearch, West 
Grove, PA) were used.  The sections were examined under an epifluorescent 
microscope (Eclipse E600; Nikon, Melville, NY) and the images were digitally 
captured (Spot RT Color; Diagnostic Instruments, Sterling Heights, MI). 
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4.2.3 Results 
 
Stretch-grown and static neural construct survival 
 
Stretch-grown constructs were harvested at the 4-week (n=6) and 8-week 
(n=2) time points. All static constructs (n=6) were harvested 4-weeks post-
transplantation.  At both time-points the transplanted area could be clearly 
identified as the collagen tube was still un-resorbed and maintained its structural 
Figure 4.4:  Static cultures of dorsal root ganglion neurons were 
clearly identified in the tube.  Clusters of cell bodies and their 
associated axonal connections (indicated by the arrows) were 
recognized using NF-200 staining (red), and could be distinctly 
identified against the host tissue (GFP, green).  Note that no co-
localization could be seen in their vicinity, indicating the lack of 
host and graft axon intermingling in the area. 
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integrity.  Within the tubes the transplanted ganglia and their axonal connections 
were identified using the neuronal/neuritic cytoskeletal protein NF-200; these 
areas did not co-localize with green fluorescent protein, indicating non-native 
tissue (Figure 4.4).  Examination of the grafts also revealed robust 
vascularization along their entire lengths, which is a necessary requirement for 
the survival and maintenance of host and graft tissue.  Also, as observed in our 
previous studies, there was no overt sign of immunologic response as denoted 
by infiltrating macrophages and neutrophils despite the lack of immune 
suppressant usage. 
 
Host regeneration across stretch-grown constructs 
Host nerve fibers were seen to extend across the length of the 1cm lesion 
in the stretch-grown as well as the static neural transplants (Figure 4.5).  
However, far most extensive host infiltration (neural and vascular) could be seen 
in the stretch-grown group, whereas the static group had preferential neurite 
growth along the walls of tube.  The host fibers were identified as those 
expressing NF-200 co-localized with GFP (Figure 4.6 A-C).  Remnants of the 
agarose were still present at 4 weeks; the axons were seen to grow between the 
agarose and the walls of the collagen tube in both cases, presumably due to the 
relative impermeability of the still-disintegrating agarose fragments.  After 8 
weeks in vivo, however, the nerve and accompanying vasculature was 
distributed through the width of the tube and the agarose could not be detected.
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Figure 4.5:  Comparison of host nerve regeneration through stretch‐grown axon group (left) and static culture group (right). In the static group, host tissue appeared to preferentially regenerate along the walls of the collagen tube, whereas tissue distribution was more uniform in the stretch‐grown axon group. 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At 4 weeks, all constructs were also seen to contain GFP+/S-100+ 
Schwann cell bodies in the vicinity of the host axon fibers (Figure 4.6D).  These 
same cell bodies did not positively express myelin basic protein (SMI-94), 
suggesting that they had not yet converted into a myelinating phenotype.   
As previously mentioned, the constructs were also evaluated at 2 weeks 
(n=2 per group). However, as no measurable differences were observed when 
compared with the 4-week time point, evaluation at 2 weeks was discontinued. 
Figure 4.6:   (A-C)  Host regeneration within the construct. NF-200 staining 
(red) was expressed by both host and graft axons.  Areas of co-localization 
(white arrow) indicate host axon fibers. (D) Schwann cells expressing S-100 
(green) surrounding host axons (red) Scale bar = 100µm. 
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Electrophysiological assessment 
 Evaluation of the electrophysiology of the repaired nerves at 4 weeks 
revealed clear differences between the stretch-grown and static groups.  The 
ratio of the conduction velocities of the treatment and contralateral control sides 
were calculated, and nerves with stretch-grown axons demonstrated a 
statistically significant improvement over static cultures.  This correlates with 
observed differences in regenerated axonal fiber density.  It should be noted that 
the recorded conduction velocities are less than twenty times that of normal 
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Figure 4.7:  Comparison of conduction velocities (CV) of the stretch-grown 
and static culture groups expressed as a percentage of the contralateral (CV).  
The difference was found to be significant (p<0.05). 
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nerves. This could be attributed in part to the still-incomplete regeneration as well 
as the previously noted absence of myelination.  
 
4.3 Attenuation of distal degeneration using a neural construct 
4.3.1 Relevant Background 
 Following the transection of a nerve, distal axons – which have been 
physically cut off from their neural cell bodies – undergo a gradual degenerative 
process known as Wallerian degeneration.  Within a few hours of transection, the 
axolemma fuses and seals the end; the axons themselves begin to disintegrate 
within a few days.  Myelin and other cellular debris are phagocytosed by 
macrophages within 6 weeks. Concurrent with the loss of the axons, Schwann 
cells begin to proliferate at the site of the injury and organize themselves into 
aligned columns known as bands of Bungner (Figure 4.8).  These Schwann cells 
upregulate their synthesis of neurotrophic factors including NGF, BDNF and NT-3 
[Heumann, 1987; Thoenen et al, 1988; Funakoshi et al, 1993; Fu and Gordon, 
1995; Raivich and Makwana, 2007] in order to attract regenerating axons of the 
proximal stump into the aligned columns.  If regeneration is successful, axonal 
sprouts will advance through the bands of Bungner and ultimately innervate their 
appropriate distal targets within a few (3-6) months of the injury.  If reinnervation 
does not occur within this timeframe, however, the recovery is likely to be 
incomplete [Fu and Gordon, 1995; Gutmann and Young, 1944].  A progressive 
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increase in the collagen content of the endoneurium and perineurium can lead to 
an inhospitable environment for regenerating axons [Salonen et al, 1985].  
However, the predominant factor contributing to this poor recovery is the gradual 
reduction of neurotrophic support and eventual disintegration of the Schwann cell 
basal lamina [Sunderland, 1950], which is almost entirely complete within 4-6 
months. 
 A variety of strategies have been investigated with the goal of delaying 
this distal atrophy and improving functional outcome.  In the case of proximal 
nerve injuries or long nerve gaps, clinicians regularly perform distal motor nerve 
transfers in order to hasten muscle reinnervation [Mackinnon, Roque and Tung, 
2007]; however, this results in impaired function at the donor site.   Moreover, in 
many situations a suitable motor nerve candidate is simply not available.  
Figure 4.8:  Example of columnar alignment of Schwann cells (S-100, green) 
in the sciatic nerve 2 weeks post-transection.   Scale bar = 50µm. 
Image courtesy Cullen DK, 2008 
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Sensory nerve innervation of the distal stump has been shown to maintain a 
favorable neurotrophic milieu for at least 6 months post-transection [Michalski et 
al, 2008; Bain et al, 2001].  Here too, however, the sacrifice of an otherwise 
healthy nerve is required for improvement of outcome at the graft site. 
 Building upon these approaches, and our observation of graft 
axons extending into the host nerve stumps [Huang J et al, 2009], we 
hypothesize that axonal processes extending from a transplanted neural 
construct may maintain the support architecture of the distal segment, potentially 
leading to improved functional recovery even after delayed reinnervation. In this 
study, we compare the extent of degeneration of the distal stump over 16 weeks 
after treatment with a transplanted static neural construct vis-à-vis no repair. 
 
4.3.2 Materials and Methods 
Dorsal root ganglion neuron isolation 
Dorsal root ganglion (DRG) neurons were isolated from embryonic day 15 
fetuses from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA) 
rats.  The DRG explants were suspended at 5x106 cells/mL in Neurobasal® 
medium supplemented with 2% B-27, 0.4 mM L-glutamine, 1% 
penicillin/streptomycin, 2 mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10 
ng/mL 2.5S nerve growth factor (NGF) and 1% fetal bovine serum (FBS) 
(HyClone, Logan, UT), and a mitotic inhibitor formulation of 10 mM 5-fluoro-2’-
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deoxyuridine (FdU) (Sigma-Aldrich), and 10 mM uridine (Sigma-Aldrich) to 
encourage non-neuronal cell elimination. 
Static Nervous Tissue Constructs 
The explants were plated into a collagen-filled (rat tail type 1, 3.67mg/mL) 
agarose (1.25% in 1X PBS; Ultrapure, Invitrogen, Carlsbad, CA) trough 
measuring 2mm x 1cm.  The cell cultures were allowed to form axonal 
connections over 12 days in vitro.  The neural growth medium described above 
was replaced on post-isolation days 1, 3, 5 and 12. 
 
Figure 4.9:  Schematic representation depicting the use of neural constructs to innervate and protect the transected distal stump 
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Neural Construct Encapsulation 
On post-isolation day 12, the neural cultures were removed from the 
incubation chambers and embedded in a collagen-based matrix (3.0 mg/mL) in 
Dulbecco’s modified Eagle’s medium supplemented with NGF (2.5S, 10 ng/mL).  
After gelation at 37°C, embedded cultures were gently removed and placed 
within a 1cm absorbable collagen nerve guidance channel (3mm inner diameter, 
NeuraGenTM, Integra LifeSciences Corp, Plainsboro, NJ). 
Peripheral Nerve Surgery and Tissue Construct Implantation 
All procedures were performed using GFP+ rats (adult male, 400-450g, 
strain TgN(act-EGFP)OsbCZ-004).  The animals were anesthetized with sodium 
pentobarbital (Nembutal, 50 mg/kg, i.p.) prior to surgery.  A longitudinal skin 
incision was made in the hind leg from the sciatic notch proximally to the region 
of the popliteal fossa distally.  The gluteal muscle was freed up to expose the 
sciatic nerve and its posterior tibial branch, and the nerve was transected 1cm 
proximal to the trifurcation.  For construct transplantations (n=6), the distal stump 
was carefully inserted into one end of the NeuraGenTM tube with an overlap of 
1mm, and the epineurium was secured to the tube using 8-0 absorbable sutures.  
The ends of the tube were sealed with salmon fibrin (5mg/mL fibrinogen, 5 NIH 
units/ml thrombin) to provide additional stability, and to attenuate macrophage 
infiltration into the tube.  For both neural construct transplantations and controls 
(n=6), the proximal stump was capped and the distal stump/tube was covered in 
a non-resorbable nylon mesh – these steps were taken in order to prevent 
  52 
inadvertent regeneration of the proximal stump into the transection site.  Finally, 
the muscle and skin layers were closed using absorbable chromic gut 4-0 
sutures. 
 
Nerve Harvest at 16 weeks and Histological Analyses  
The surgical site was re-exposed at the 16-week time point (with the 
exception of one neural construct graft and one control nerve that was left in vivo 
for 8 months), and the distal stumps were harvested by transecting the nerve as 
far as could be exposed distal to the graft (typically 1cm).  The nerves and were 
immediately placed in 4% paraformaldehyde and the animals were euthanized by 
an overdose of sodium pentobarbital. 
Following overnight fixation in paraformaldehyde, the excised tissue was 
removed and immersed in 30% sucrose solution.  The tissue was then 
cryosectioned longitudinally (15-25µm), and immunostained for (i) neurofilament-
200kDa (NF-200; N0142, 1:200; Sigma-Aldrich), (ii) S-100 (1:250; Dako, 
Carpinteria, CA), or (iii) calcitonin gene-related peptide (CGRP; C8198, 1:1000 
Sigma-Aldrich). The appropriate secondary fluorophore-conjugated antibodies 
(TRITC- or AMCA-conjugated IgG; Jackson ImmunoResearch, West Grove, PA) 
were used.  The sections were examined under an epifluorescent microscope 
(Eclipse E600; Nikon, Melville, NY) and the images were digitally captured (Spot 
RT Color; Diagnostic Instruments, Sterling Heights, MI). 
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4.3.3 Results 
 
Distal stump harvest and gross assessment at 16 weeks 
Distal stumps from both groups (neural constructs and controls) were 
evaluated at the 16-week time point.  One non-treated control nerve could not be 
harvested, as the distal pathway appeared to have completely disintegrated. 
Aberrant regeneration of the proximal stump into the distal pathway was not seen 
in any of the animals.  The neural constructs could be easily identified by means 
of the collagen tubes, which had still not been completely resorbed and 
maintained their structural integrity; the nerve stumps remained securely 
attached to the tubes.  The remaining control nerves could be readily located 
beneath the non-resorbable nylon mesh protective sheaths.  A pre-histological 
comparison of the nerves revealed narrower diameters for the control group in 
relation to treated nerves.  On average, control nerves were 13.6% smaller in 
diameter than the treated group, and 20.8% narrower than uninjured nerves.  
 
Basal lamina alignment and neural construct survival 
At the 16-week time point, all distal stumps from both groups contained 
intact epineuria and living Schwann cells within them.  Schwann cells were 
identified as those expressing S-100 co-localized with GFP.  Within nerves 
attached to static neural constructs, the Schwann cells were aligned in columnar 
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formations similar to those observed within 2 weeks of nerve transection (Figure 
4.10 A-C).  In contrast, control nerves did not exhibit this organized Schwann cell 
alignment (Figure 4.10 D-F).  Despite this disparity, neither dorsal root ganglia 
nor host/graft axons could be detected within these columns using NF-200, GAP-
43 and CGRP staining, suggesting that the neural populations were no longer 
present at this time point. 
Figure 4.10:  The distal nerve stump at the 4-month time point.  The treated nerve 
(A) was stained for S-100 (red, B) and the super-imposed image (C) revealed 
columnar alignment of Schwann cells (yellow) similar to that seen within a few weeks 
of transection.  On the other hand, control nerves (D), when stained for S-100 (E) 
revealed a disorganized arrangement of Schwann cells (yellow, F), as is typically 
expected at this time point. Scale bar = 100µm. 
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4.4 Discussion 
In order for peripheral nerve regeneration to be considered successfully, 
axons must grow across the lesion, through the distal pathway and finally 
integrate functionally with the appropriate end targets.  If this does not occur 
promptly, the distal pathway will disintegrate and the regeneration will be 
incomplete.  In this project, living tissue-engineered neural constructs, created 
using a novel stretch-growth paradigm, were used to (1) bridge a 1cm peripheral 
nerve lesion, and (2) delay the atrophy of the distal stump support architecture.   
 
Repair of a PNS lesion: 
The ability of stretch-grown axons to bridge nerve lesions has already 
been shown in previous experiments [Huang et al, 2009; Iwata et al, 2006].  In 
this study, the regenerative assistance provided by these stretch-grown 
constructs was compared to that provided by non-elongated cultures of dorsal 
root ganglion neurons.  This was performed in order to confirm that it is indeed 
the presence of elongated axon bundles that contribute to enhanced 
regeneration, and not the cell bodies.  The repaired nerves were evaluated at 4 
weeks and 8 weeks.  By 4 weeks, the nerves had regenerated in all surviving 
animals.  At this time-point, the agarose in the tubes was still largely undigested; 
indeed the axons appeared to flank the agarose portions and grow along the 
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edges of the tubes.  The persistence of the agarose at 4 weeks was surprising as 
it contradicts previously published reports where agarose was used as a 
regenerative substrate [Balgude et al 2001].  A possible explanation is the use of 
salmon fibrin as a sealant at the ends of the tube.  Salmon fibrin has been shown 
to attenuate the infiltration of macrophages, which are known to contribute to the 
enzymatic degradation of agarose.  In any event, the agarose is not seen at 8 
weeks and the tubes solely include host and graft axons as well as 
accompanying vasculature. 
Despite the uniformly obstructive nature of the agarose at 4 weeks, cross-
sections of the harvested constructs revealed a greater number of host axons in 
stretch-grown constructs than in the non-elongated group.  A likely explanation 
for this is the preference for regenerating neurites to coalesce around and grow 
along longitudinally-aligned fibers within a regenerative matrix [Clements IP et al, 
2009; Kim YT et al, 2008]; indeed, these axons appear to be intertwined with 
graft fibers.  It is well established that regenerating neurites project an 
abundance of collateral branches that are pruned once the distal target is 
reached [Witzel et al, 2005; Jenq and Coggeshall, 1985].  The ultimate success 
of any graft is highly dependant on the generation of these surplus branches 
[Madison et al, 2007], and thus the observed axon density within the stretch-
grown constructs is promising. 
Clusters of Schwann cells were also identified adjacent to the host axon 
fibers.  Intriguingly, these cells stained positively for S-100 but not for SMI-94.  
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Unlike S-100, SMI-94 is specific to myelin and does not identify non-myelinating 
or neoplastic cells (Clark HB et al, 1985) suggesting that these Schwann cells 
had not converted to a myelinating phenotype at 4 weeks. However, myelination 
of the regenerated axons was observed by the 16 week time point [Huang J et al, 
2009], indicating that the phenotypic conversion occurs somewhere within this 
time frame.  Indeed, regenerated axon myelination has been typically reported at 
2 months, and tends to steadily increase from 2-12 months [Mackinnon S et al, 
1991]. 
Electrophysiological evaluation was the clearest indicator of the 
differences between the two groups.  The conduction latency across each 
transplant in response to a stimulus pulse train was measured from which the 
nerve conduction velocities (NCV) were evaluated.  The NCV was then 
normalized to contralateral nerve for each animal.  This particular metric was 
chosen as a consequence of the size disparity between the animals.  A 
comparison between the groups revealed a statistically significant improvement 
in animals with stretch-grown transplant in relation to the static group.  This 
finding can be attributed to the observed difference in the axonal fiber 
distributions between the two groups.  It should be noted that the observed 
velocities are approximately 20 times less than those of the non-injured nerves.  
This can attributed to a number of reasons, principal of which is the absence of 
myelination at 4 weeks - saltatory conduction can often occur at up to a hundred 
times the speed of a simple action potential.  Axon fiber caliber also plays a 
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significant role.  Regenerating fibers are known to be of a narrower diameter until 
they integrate with their end targets, after which they significantly increase in 
girth.  
The use of living axon grafts may enable the creation of alternative 
pathways for communicating motor and sensory signals.  Indeed, stretch-grown 
axons in vitro have been shown to be electrophysiologically functional including 
intra-culture synaptic integration [Pfister BJ et al, 2006].  However, preliminary 
work evaluating the presence of synaptophysin, a protein concentrated in pre-
synaptic specializations, did not reveal evidence of host/graft synaptic 
integration.  Alternative analyses techniques, such as morphological identification 
of putative synapses via electron microscopy, may further illuminate this 
important consideration. 
 
Attenuation of Distal Degeneration: 
 The eventual atrophy of the distal stump is a confounding factor when 
nerve lesions are either too large or too proximally located.  Efforts have been 
made to delay this atrophy using sensory nerve innervation; so far, however, no 
one method is capable of both promoting regeneration and attenuating distal 
degeneration. 
 In this study, cultures of dorsal root ganglion neurons were encapsulated 
and affixed to a transected sciatic nerve distal stump, in order to determine if 
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axonal outgrowth and its associated neurotrophic support could maintain neural 
support cells over a period of 4 months.  The increased degree of atrophy in 
control nerves was immediately apparent during nerve harvest – while their 
epineuria were still intact, untreated nerves were of considerably narrower caliber 
than those attached to the neural constructs.  Control nerves also appeared 
structurally less robust, making them difficult to manipulate and harvest.  In 
contrast, the treated distal stumps were noticeably more robust. 
 Histological analysis of the nerves revealed clear differences in the 
alignment of survival Schwann cells in both groups.  Nerves affixed with neural 
constructs contained aligned columns of Schwann cells, similar to the bands of 
Bungner observed in the initial weeks following axotomy.  In contrast, Schwann 
cells in control nerves were distributed in a haphazard manner.  The columnar 
alignment of Schwann cells is essential for accurate guidance of the regenerating 
neurites to their appropriate targets; without this guidance, axons may 
occasionally grow along the epineuria directly onto the denervated muscle 
surface, resulting in poor reinnervation [Fu and Gordon, 1995].  Absent this path 
as well, uncapped axons will innervate surrounding muscle targets, resulting in 
the phenomenon of phantom pain. 
 Despite these observed differences, the neural constructs could not be 
detected within the collagen tubes at 4 months, preventing a thorough 
assessment of its’ contributions.  This was surprising, since neural constructs 
used for lesion repair were observed within the transplanted area at the same 
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time point.  However, a critical difference between these two results is the 
attachment of the proximal stump and subsequent regeneration.  The milieu 
surrounding the regenerating nerve is flush with neurotrophic support; however, 
on the distal side this support is transient, after which the support structures 
undergo aggressive macrophagic degradation [Hoke et al, 2003].  Immune 
suppressants, which were not employed in this study, might be a potential means 
of prolonging grafted neuron survival. 
 
4.5 SUMMARY OF FINDINGS 
Conclusions 
From these results, we infer that the stretch-grown axonal constructs 
provide a degree of physical and neurotrophic support to the regenerating 
proximal stump that is absent when using populations of neural cell bodies alone.  
Neural cell bodies do not exist outside of the spinal cord and its immediate 
vicinity, suggesting that they may be physiologically irrelevant to outgrowing PNS 
neurites.  Living axons, on the other hand, have been shown to play a critical role 
during embryonic development and in regeneration (such as after crush injury), 
and thus may be the essential element of any tissue-engineering approach that 
utilizes neural cellular components.  At the distal end, infiltrating neurites from the 
transplanted neural constructs may provide a measure of trophic support that can 
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maintain the existing architecture for several months.  While this support appears 
to be temporary, it may be sufficient for all but the most extensive of lesions. 
 
Limitations and Future Studies 
 While the results are suggestive of a beneficial effect from the 
transplanted neural constructs at both the proximal and distal ends, a larger 
study encompassing more acute and long-term time points is needed to support 
these findings.  In particular, a more thorough quantification of axon proliferation, 
myelination and electrophysiology at various time points must be performed.  In 
addition, the distal stump maintenance must be evaluated (a) at an earlier time 
point in order to assess the effect of the neural constructs, and (b) using immune 
suppressants in order to evaluate their ability to promote construct survival over 
longer periods.  
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Chapter 5:  Development of a Neural Interface Platform 
with the Peripheral Nervous System Using Stretch-
Grown Axonal Constructs 
 
5.1 Overview 
Technological advances of the past several decades have now made 
interfaces with the nervous system a reality.  The cochlear implant, the first 
device to truly interface the nervous system with the external environment, was 
developed in the 1960’s.  However, the direct neural control of prosthetic limbs is 
a far more nascent field. In 1999, a seminal study described the control of a 
robotic arm using signals directly derived from the rat motor cortex [Chapin et al, 
1999].  Since then, there have been a number of exciting advancements in the 
field, in both central- (CNS) and peripheral nervous system (PNS) based 
approaches. 
The ideal neuroprosthesis should be a functional facsimile of the 
amputated limb, i.e. it must facilitate continuous bi-directional communication 
between the central nervous system and the external environment.  Currently, 
the vast majority of efforts in this area focus exclusively on the re-establishment 
of motor control, relying on visual feedback to guide the movement of the 
prosthesis.  However, in order to achieve truly “normal” interaction with the 
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surroundings, tactile feedback is vital.  Additionally, from a clinical and 
rehabilitation standpoint, it is important to have an architecture that minimizes 
surgical complexity and recovery time, provides a hospitable environment for 
nerve survival, and lends itself to rapid learning.   
Over the past several decades a variety of architectures that target both 
the central and peripheral nervous systems have been developed.  CNS-based 
approaches attempt to restore motor function by directly deriving commands from 
the patient’s motor cortex.  Two major strategies have emerged to accomplish 
this.  The first is a non-invasive technique to obtain movement intent via surface 
(scalp) electrodes over the motor cortex [Guger C et al, 1999; Wolpaw JR and 
MacFarland DJ, 2004].  Using this approach, which entirely avoids the risks 
associated with surgery, patients have demonstrated the ability to perform such 
tasks as cursor manipulation and even basic word processing (Figure 5.1, right). 
However, the poor information transfer rates associated with this 
technique makes its translation to the control of more sophisticated systems 
immensely challenging in the near future [Wolpaw JR et al, 2002; Lebedev MA et 
al, 2006].  To produce complex signal integration, more invasive methods have 
been developed, such as chronically implanted micro- electrodes into the motor 
cortex (Figure 5.1, left) or spinal cord to locally record activity from a select 
population of neurons [Palmer C, 1978; Maynard EM et al, 1999; Donoghue JP, 
2002; Taylor DM et al, 2002; Hochberg LR et al, 2006].  Neuronal population 
decoding algorithms are then used to decipher the recorded signals in real-time.  
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This approach has yielded considerable success in re-enabling motor control; 
indeed, a version of this system is currently the subject of a pilot clinical trial.  
Nonetheless, this approach has a number of drawbacks, including substantial 
computational complexity, significant clinical risk arising from the chronic 
implantation of electrodes in healthy neural tissue, and signal attenuation and/or 
remapping due to scar formation.  Moreover, findings from functional magnetic 
resonance imaging (fMRI) studies indicate that there is extensive and dynamic 
overlap of the cortical representations of different limb regions, adding additional 
Figure 5.1:  Examples of CNS‐based brain‐machine interface systems.  Top left – a penetrative 10x10 cortical electrode array.  Bottom left – after removal of the skull bone, the electrode array is inserted into the motor cortex tissue.  Recorded cortical activity is transmitted to a pedestal connection implanted in the skull bone, which is then interpreted by an external computer.  Right – EEG‐derived neural interface system using a sensor array mounted on the user’s scalp. 
Donoghue JP, 2002; Wolpaw JR et al, 2004 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difficulty to implant positioning and signal decoding [Rao SM et al, 1995].  
Additionally, there is still no clear approach to relay sensory signals/feedback.  
Alternatively, interface approaches outside the CNS typically take one of 
two forms – (1) electrodes that are implanted in or around the damaged 
peripheral nerve, or (2) electrodes that are implanted within, or on the surface of, 
skeletal muscle [Navarro X et al, 2005].  Nerve electrodes, the form of which can 
vary from encircling nerve cuffs [Grill WM and Mortimer JT, 1998] to intra-
Figure  5.2:    Top  –  Non‐penetrative  nerve  cuff  electrode.    The electrode is wrapped around the nerve, and can be tightened to create a  more  secure  connection.    Bottom  –  a  10x10  penetrating intrafascicular  electrode  array.    The  array  is  inserted  into  the  nerve, and  the  varying  electrode  lengths  enable  recording  from  fascicles  at varying depths. 
Navarro et al, 2005 and Branner et al, 2001 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fascicular penetrating electrode arrays [Warwick K et al, 2003; Branner A et al, 
2004] exhibit both enhanced signal selectivity and high signal-to-noise ratio.  
However, this approach still has its drawbacks – the materials used are often of 
poor biocompatibility, the electrodes themselves can be extremely damaging to 
the already traumatized nerves, and there is a reduced likelihood of chronic 
interface due to nerve degeneration. 
EMG-based myoelectric prosthesis systems have met with remarkable 
success in recent years.  In particular, the targeted innervation of the brachial 
plexus nerves into the pectoral muscles has allowed for the real-time control of 
multi-jointed prosthetic limbs [Kuiken TA et al, 2004; Kuiken TA et al, 2007a], as 
Figure 5.3:  Brain‐machine interface using targeted innervation of the brachial plexus nerves.  The pectoral muscle is separated in four distinct regions, and each brachial plexus nerve is allowed to innervate a separate area.  Surface electrodes placed over the muscle tissue detect the movement intention. 
Kuiken et al, 2007 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well as the transmission of sensory modalities including touch and pain [Kuiken 
TA et al, 2007b] to the CNS (Figure 5.3).  Although with extremely beneficial 
practical applications for patients in the near future, this approach has clear 
limits; not only must healthy muscle tissue be compromised in order to provide a 
target for regeneration, but also the recovery time and first indications of 
reinnervation can be in the order of several months. 
While tremendous advancements have been made, there is no approach 
to date that directly integrates with the nervous system while leveraging the 
processing abilities of the brain and spinal cord.  In contrast to all other strategies 
for neural interface development, we propose to exploit a novel method of 
engineering nervous tissue constructs as a means of interfacing a multi-electrode 
array (MEA) with regenerating peripheral nerves.  The use of living neural tissue, 
which may be coupled to the MEA to form a stable interface prior to 
transplantation, provides an enticing target for host axon ingrowth and synaptic 
integration (Figure 5.4).  By directly accessing the transected nerve, we eliminate 
the need for interpreting computationally complex neural signals in the CNS.  
Instead, upon integration, simple operant conditioning should allow the implantee 
to control the prosthesis with ease [Dhillon GS et al, 2004].  Thus, our approach 
builds upon current interface architecture capabilities and holds enormous 
promise to provide both motor control and sensory feedback for normal function.  
  
 
  69 
 
 
5.2 Extension and maintenance of host neurites in the absence 
of a living distal target, using stretch-grown axons 
 
5.2.1 Relevant Background 
When a short segment of a nerve is lesioned, regenerating fibers will 
regenerate across the gap and along the distal segment until the end target is 
reached.  However, if a living distal target is absent, or if the regenerative path is 
occluded, the axons will retract and sprout collateral branches, each attempting 
to forge a course to the end organ.  If this too is not possible, the axons will either 
inaccurately innervate surrounding tissue (resulting in the phenomenon of 
Figure 5.4:  Schematic representation describing the use of stretch‐grown axonal constructs pre‐attached to an electrode array in a PNS‐based neural interface system 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phantom pain, which occurs in approximately 10% of patients [Herndon JH et al, 
1976]) or will form a painful bulbous enlargement at the site known as a neuroma 
[Fried K et al, 1993].  This entire process can occur within weeks, and neuromas 
can often persist for months to years. 
In general, the fate of a nerve and its end target are considered to be 
interlinked – a severed nerve is continuously attempting to reach the target, and 
denervated end targets require subsequent reinnervation for their long-term 
survival.  In order to create a viable neural-electrical interface with a peripheral 
nerve, it is crucial that the nerve fascicles be prevented from retracting from the 
vicinity of electrode sensors and/or forming a neuroma at the site.   In this study, 
we evaluate the ability of a stretch-grown neural construct to sustain regenerating 
axons for up to 4 weeks in vivo in the absence of a distal target, vis-à-vis static 
neural constructs.  
 
5.2.2 Materials and Methods 
Dorsal root ganglion neuron isolation 
Dorsal root ganglion (DRG) neurons were isolated from embryonic day 15 
fetuses from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA) 
rats.  The DRG explants were suspended at 5x106 cells/mL in Neurobasal® 
medium supplemented with 2% B-27, 0.4 mM L-glutamine, 1% 
penicillin/streptomycin, 2 mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10 
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ng/mL 2.5S nerve growth factor (NGF) and 1% fetal bovine serum (FBS) 
(HyClone, Logan, UT), and a mitotic inhibitor formulation of 10 mM 5-fluoro-2’-
deoxyuridine (FdU) (Sigma-Aldrich), and 10 mM uridine (Sigma-Aldrich) to 
encourage non-neuronal cell elimination.   
 
Static Nervous Tissue Constructs 
The explants were plated into a collagen-filled (rat tail type 1, 3.67mg/mL) 
agarose (1.25% in 1X PBS; Ultrapure, Invitrogen, Carlsbad, CA) trough 
measuring 2mm x 1cm.  The cell cultures were allowed to form axonal 
connections over 12 days in vitro.  The neural growth medium described above 
was replaced on post-isolation days 1, 3, 5 and 12. 
 
Stretch-grown Nervous Tissue Constructs 
The explants were plated into mechanical elongation chambers custom-
fabricated for the stretch-growth procedure.  The neurons were plated in two 
populations along the interface of a collagen-coated (rat tail type 1, 3.67mg/mL) 
aclar “towing” membrane and a base layer of agarose (1.25% in 1X PBS; 
Ultrapure, Invitrogen, Carlsbad, CA), resulting in a separation of 50-100µm.  Over 
5 days in vitro, axonal connections were formed between these two populations.  
The populations were then gradually separated over the course of 7 days using a 
stepper motor system until the axons spanning them reach a length of 1cm. 
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Neural Construct Encapsulation 
On post-isolation day 12, the neural cultures (both static and stretch-
grown) were removed from the incubation chambers and embedded in a 
collagen-based matrix (3.0 mg/mL) in Dulbecco’s modified Eagle’s medium 
supplemented with NGF (2.5S, 10 ng/mL).  After gelation at 37°C, embedded 
cultures were gently removed and placed within a 1cm absorbable collagen 
nerve guidance channel (3mm inner diameter, NeuraGenTM, Integra LifeSciences 
Corp, Plainsboro, NJ). 
 
Peripheral Nerve Surgery and Tissue Construct Implantation 
Stretch-grown (n=6) as well as static (n=6) constructs were implanted into 
GFP+ rats (adult male, 400-450mg, strain TgN(act-EGFP)OsbCZ-004).  The 
animals were anesthetized with sodium pentobarbital (Nembutal, 50 mg/kg, i.p.) 
prior to surgery.  A longitudinal skin incision was made in the hind leg from the 
sciatic notch proximally to the region of the popliteal fossa distally. The gluteal 
muscle was freed up to expose the sciatic nerve and its posterior tibial branch, 
and the nerve was transected 1cm proximal to the trifurcation.  The proximal 
stump was carefully inserted into the NeuraGenTM tube with an overlap of 1mm, 
and the epineurium was secured to the tube using 8-0 absorbable sutures.  Both 
ends of the tube were sealed with salmon fibrin (5mg/ml fibrinogen, 5 NIH 
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units/ml thrombin) to provide additional stability. A sterilized strip of polyimide 
was then placed over the distal end of the tube and secured to the surrounding 
muscle in order to prevent axonal growth out of the tube.  Finally, the muscle and 
skin layers were sutured over the graft with absorbable chromic gut 4-0 sutures. 
 
Nerve Harvest and Histological Analyses  
Figure 5.5:  The transplanted neural construct (indicated by the arrow) being harvested at the 4‐week time point.  The construct could be seen securely connected to the proximal stump.  Evidence of fibrosis and vascularization could be seen along the outside walls of the collagen tube. 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At 4 weeks post-transplantation, the constructs were harvested by 
transecting the nerve 2mm proximal to the graft (Figure 5.5), and were placed in 
4% paraformaldehyde.  The animals were euthanized by an overdose of sodium 
pentobarbital. 
Following overnight fixation in paraformaldehyde, the excised tissue was 
removed and immersed in 30% sucrose solution.  The tissue was then 
cryosectioned longitudinally (15-25µm), and immunostained for (i) neurofilament-
200kDa (NF-200; N0142, 1:200; Sigma-Aldrich), (ii) myelin basic protein (MBP; 
SMI-94R, 1:500, Covance Research Products, Princeton, NJ), (iii) S-100 (1:500; 
Dako, Carpinteria, CA), or (iv) calcitonin gene-related peptide (CGRP; C8198, 
1:1000 Sigma-Aldrich). The appropriate secondary fluorophore-conjugated 
antibodies (TRITC- or AMCA-conjugated IgG; Jackson ImmunoResearch, West 
Grove, PA) were used.  The sections were examined under an epifluorescent 
microscope (Eclipse E600; Nikon, Melville, NY) and the images were digitally 
captured (Spot RT Color; Diagnostic Instruments, Sterling Heights, MI). 
 
5.2.3 Results 
 
Host axonal regeneration into stretch-grown constructs 
Host axon fibers were seen to extend into the construct tubes and could 
be found along their entire length.  These axons were identified as those 
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expressing NF-200 co-localized with GFP.  Similar to observations in the 
previous study, the axons were observed to preferentially grow between the still-
disintegrating agarose segments and the walls of collagen tube, although in n=4 
of 6 cases they did not cross the distal end of the tube. Robust vascularization 
could be seen throughout the tubes and alongside the axons.  In regions with 
axonal sprouting, co-mingling of host and graft (NF200+/GFP-) axonal fibers 
could be observed, indicating survival of the graft axons (Figure 5.6). There was 
no overt sign of immunologic response as denoted by infiltrating macrophages 
and neutrophils despite the lack of immune suppressant usage. 
 
Neuroma formation in static constructs 
In the case of static neural constructs (n=6 of 6), the attached nerves 
appeared to have undergone excessive collateral sprouting resulting in neuroma-
like formations by the proximal opening (Figure 5.7).  The axons within the nerve 
bundles could be clearly identified morphologically, and were also seen to 
express GAP-43 co-localized with GFP, a commonly observed marker in 
neuromas.  Sparse vascularization was seen within the tube. Neither NF-200, nor 
GAP-43 nor CGRP were expressed in these vascularized areas or in any other 
area of the tube, suggesting that the transplanted cell bodies were no longer 
present. Here too, there was no sign of macrophage or neutrophil infiltration at 
this time point. 
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Figure 5.6:  Cross section of the stretch‐grown axonal construct in the collagen tube (A).  The arrow indicates the proximal side.  Robust axonal and vascular infiltration can be seen within the tube, as well as empty pockets containing un‐disintegrated agarose.  No axonal outgrowth was observed leaving the distal end of the tube.  GFP tissue can be seen flanked between the tube walls and agarose (B).  Staining for NF‐200 (red) revealed axons in these areas (C).  Superimposition of these images revealed robust intermingling of host (yellow) and graft axons (red).  Scale bars = 100µm. 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Figure 5.7: Cross section of the static neural construct in the collagen tube (A).  
The arrow indicates the proximal side.  Large empty regions could be seen 
throughout the tube.  Note the neuroma formation at the proximal stump, as 
characterized by the excessive localized collateral sprouting and positive 
identification for GAP-43 (red, B).  No axonal ingrowth or graft cell survival 
could be seen within the tube, as evidenced by the lack of positive staining for 
NF-200.  However, vascular infiltration could be clearly observed (C).  Scale 
bars  = 100µm. 
A B 
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5.3 Regeneration and maintenance of host axons in the vicinity 
of a flexible electrode substrate 
 
5.3.1 Relevant Background 
Currently, direct stimulating/recording techniques from peripheral nerves 
can be broadly grouped into two categories.  The first are nerve cuffs, which 
have been in clinical usage since the 1960’s and have been implanted in some 
patients for as long as 15 years [Glenn WWL et al, 1985; Waters et al, 1985].  
These are typically made of inert materials such as platinum-iridium or stainless 
steel, encircle the nerve externally and thus do not inflict any direct penetrative 
damage to the underlying axonal cytoskeletal structures [Heiduschka and 
Thanos, 1998; Naples et al, 1990].  They are also available in a variety of 
geometries such as helices [McCreery et al, 1992] and spiral cuffs [Rozman, 
1991] that optimize the contact between the nerve and electrode. However, this 
design has inherent drawbacks – the electrodes can often impose stretching and 
compressive forces on the nerve, the materials can degrade over time, and there 
is a reduced likelihood of chronic interface due to nerve degeneration [Krarup et 
al, 1989; Larsen et al, 1998]. 
The second category of nerve-electrodes is intra-fascicular arrays.  These 
electrodes penetrate at various depths into the nerve depending upon the degree 
of sensitivity and control desired [Branner et al, 2004; Lawrence et al, 2003; 
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Aoyagi et al 2003].  In the short term, they have been to exhibit enhanced signal 
selectivity and high signal-to-noise ratio. However, similar to nerve cuffs, this 
approach also has its disadvantages – the materials used are often of poor 
biocompatibility, the electrodes themselves can be extremely damaging to the 
already traumatized nerves, and nerve degeneration ultimately results in a loss of 
the neural-electrical interface. 
Building upon the previous study, here we assess axonal growth towards 
a thin, flexible polyimide electrode array substrate pre-attached to the axonal 
constructs (Figure 5.8), and determine the proximity of regenerating axons to the 
substrate surface.  From these observations, we can make a preliminary 
assessment of the feasibility of recording electrophysiological activity from the 
Figure 5.8:  Schematic of proposed neural interface design. The electrode array is attached to one population of neurons prior to axonal elongation. After stretch‐growth to 1cm, the construct is embedded in a hydrogel substrate, placed in a resorbable NeuragenTM tube for structural support, and sutured to the proximal nerve stump.  
Image of FlexMEA array, Multi Channel Systems 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nerve using this approach. 
5.3.2 Materials and Methods 
Dorsal root ganglion neuron isolation 
Dorsal root ganglion (DRG) neurons were isolated from embryonic day 15 
fetuses from timed-pregrant Sprague-Dawley (Charles River, Wilmington, MA) 
rats.  The DRG explants were suspended at 5x106 cells/mL in Neurobasal® 
medium supplemented with 2% B-27, 0.4 mM L-glutamine, 1% 
penicillin/streptomycin, 2 mg/mL glucose (Sigma-Aldrich, St. Louis, Mo), 10 
ng/mL 2.5S nerve growth factor (NGF) and 1% fetal bovine serum (FBS) 
(HyClone, Logan, UT), and a mitotic inhibitor formulation of 10 mM 5-fluoro-2’-
deoxyuridine (FdU) (Sigma-Aldrich), and 10 mM uridine (Sigma-Aldrich) to 
encourage non-neuronal cell elimination.   
 
Stretch-grown Nervous Tissue Constructs 
The explants were plated into mechanical elongation chambers custom-
fabricated for the stretch-growth procedure.  The neurons were plated in two 
populations along the interface of a collagen-coated (rat tail type 1, 3.67mg/mL) 
aclar “towing” membrane and a base polyimid strip layered on an agarose bed 
(1.25% in 1X PBS; Ultrapure, Invitrogen, Carlsbad, CA), resulting in a separation 
of 50-100µm.  Over 5 days in vitro, axonal connections were formed between 
these two populations.  The populations were then gradually separated over the 
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course of 7 days using a stepper motor system until the axons spanning them 
reach a length of 1cm. 
 
Neural Interface Encapsulation 
On post-isolation day 12, the polyimid/neural cultures (both static and 
stretch-grown) were removed from the incubation chambers and embedded in a 
collagen-based matrix (3.0 mg/mL) in Dulbecco’s modified Eagle’s medium 
supplemented with NGF (2.5S, 10 ng/mL).  After gelation at 37°C, embedded 
cultures were gently removed and placed within a 1cm absorbable collagen 
nerve guidance channel (3mm inner diameter, NeuraGenTM, Integra LifeSciences 
Corp, Plainsboro, NJ). 
 
Peripheral Nerve Surgery and Interface Implantation 
The stretch-grown constructs (n=4) were implanted into GFP+ rats (adult 
male, 400-450mg, strain TgN(act-EGFP)OsbCZ-004).  The animals were 
anesthetized with sodium pentobarbital (Nembutal, 50 mg/kg, i.p.) prior to 
surgery.  A longitudinal skin incision was made in the hind leg from the sciatic 
notch proximally to the region of the popliteal fossa distally.  The gluteal muscle 
was freed up to expose the sciatic nerve and its posterior tibial branch, and the 
nerve was transected 1cm proximal to the trifurcation.  The proximal stump was 
carefully inserted into the NeuraGenTM tube with an overlap of 1mm, and the 
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epineurium was secured to the tube using 8-0 absorbable sutures (Figure 5.9A).  
Both ends of the tube were sealed with salmon fibrin (5mg/ml fibrinogen, 5 NIH 
units/ml thrombin) to provide additional stability.  A sterilized strip of polyimide 
was then placed over the distal end of the tube and secured to the surrounding 
muscle in order to prevent axonal growth out of the tube.  Finally, the muscle and 
skin layers were sutured over the graft with absorbable chromic gut 4-0 sutures. 
 
Neural Interface Harvest and Histological Analyses  
At 4 weeks post-transplantation, the constructs were harvested by 
transecting the nerve 2mm proximal to the graft, and were placed in 4% 
paraformaldehyde.  The animals were euthanized by an overdose of sodium 
pentobarbital. 
Following overnight fixation in paraformaldehyde, the excised tissue was 
removed and immersed in 30% sucrose solution.  The tissue was then 
cryosectioned longitudinally (15-25µm), and immunostained for (i) neurofilament-
200kDa (NF-200; N0142, 1:200; Sigma-Aldrich), (ii) myelin basic protein (MBP; 
SMI-94R, 1:500, Covance Research Products, Princeton, NJ), (iii) S-100 (1:250; 
Dako, Carpinteria, CA), or (iv) calcitonin gene-related peptide (CGRP; C8198, 
1:1000, Sigma-Aldrich). The appropriate secondary fluorophore-conjugated 
antibodies (TRITC- or AMCA-conjugated IgG; Jackson ImmunoResearch, West 
Grove, PA) were used.  The sections were examined under an epifluorescent 
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microscope (Eclipse E600; Nikon, Melville, NY) and the images were captured 
digitally (Spot RT Color; Diagnostic Instruments, Sterling Heights, MI). 
 
5.3.3 Results 
Gross assessment of neural interface at 4 weeks 
 At the 4-week time point, the surgical site was re-exposed and the neural 
interface was harvested.  Fibrosis could be seen surrounding the collagen tube, 
but surprisingly the polyimide strip was spared.  The polyimide strip/electrode 
array was still securely contained within the collagen tube, despite normal 
ambulatory movement by the animal during this time (Figure 5.9B).  Within the 
tube, the proximal stump was seen to have grown into intimate contact with the 
electrode array, and both the nerve and electrode array were still secured in 
place by the surrounding agarose hydrogel [Figure 5.9C]. 
 
Axonal outgrowth in the vicinity of the electrode substrate 
A histological evaluation of the constructs revealed host axonal outgrowth in the 
immediate vicinity of the polyimide strip.  NF-200+ (Figure 5.10D) and tau-positive 
(Figure 5.10B,C) staining was observed at distances ranging from 100-200um 
from the substrate.  Vascular ingrowth was also observed in the region, 
portending well for continued survival of these axons. 
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Figure 5.9:  (A) The neural interface, consisting of the stretch‐grown axons attached to the polyimide substrate (indicated by the arrows) within a NeuraGenTM tube being sutured to the proximal stump of the rat sciatic nerve.   (B) The neural interface being harvested at the 4‐week time point. Note the fibrosis surrounding the tube, but minimal response by the polyimide strip.   (C) Visual assessment within the tube revealed the proximal stump in close physical proximity to the end of the polyimide strip. 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Figure 5.10:  (A) Cross section of the harvested neural interface at 4 weeks.  The polyimide strip (black arrow) and the proximal stump (red arrow) can be clearly seen.  (B‐C)  Axon fibers, identified by tau‐positive staining (red) can be clearly seen in close proximity to the polyimide electrode array (white arrow).  (D) Regenerating axons, identified by NF‐200 staining (yellow) can be seen within host tissue (GFP, green) running closely alongside the polyimide strip (white arrow).  Scale bar = 100µm. 
D 
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5.4 Discussion 
This project demonstrates a means of extending and maintaining a transected 
nerve segment in the absence of a distal pathway, with the goal of ultimately 
recording electrophysiological signals from the host axons using an implanted 
electrode array.  While the results are admittedly preliminary, they provide 
support for further study and development of this novel PNS-based neural 
interface platform. 
 
Extension and maintenance of regenerating neurites 
A confounding factor in the development of peripheral nerve-based neural 
interface systems has been the inability to preserve electrical contact with the 
remaining nerve segment over the long-term.  The primary reason for this is the 
unfavorable, and often physically damaging, environment created around the 
nerve fascicles when rigid metal electrodes are placed in their immediate vicinity 
[Navarro X et al, 2005]. The presence of the electrodes invariably triggers a 
robust immunologic response and connective tissue buildup, rendering the 
neural-electrical coupling ineffectual over the long-term [Stieglitz T, 2004; Larsen 
et al, 1998].  In addition, the electrodes themselves can cause compressive 
and/or penetrative stress on the neurites, further harming already impaired 
nerves [Rodriguez FJ et al, 2000; Grill WR and Mortimer JT, 1998].   
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A successful PN interface design must therefore incorporate components 
that actively encourage neurite outgrowth towards them, in addition to being 
compliant enough to prevent damage during the course of normal activity.  Since 
Schwann cells play a pivotal role in regeneration, they have been extensively 
used in so-called hybrid interface designs.  The most sophisticated of these are 
regenerative sieve electrodes – in this design, axons are induced to grow across 
a finely perforated barrier into a chamber containing a short segment of distal 
nerve and Schwann cell cultures [Lago N et al, 2009].  Axons have been shown 
to grow into the chamber and survive for several months.  However, there are a 
number of disadvantages with this approach including the limited regeneration 
across the barrier, frequent axotomy that occurs during normal ambulatory 
movement, neuroma formation over the short-term, competition between neurites 
and proliferating Schwann cells for volume, and the eventual atrophy and 
retraction of the axons [Navarro X et al, 2005].  
Building upon these studies and our previous results where it was shown 
that living stretch-grown axonal constructs provide regenerative support for 
transected fascicles, their ability to maintain axons in the absence of a distal 
target was initially evaluated in this study.  Neural constructs (stretch-grown, 
static and control) were transplanted against a transected proximal nerve 
segment, and the extent of axonal ingrowth was measured.  At 4 weeks, 
extensive axonal sprouting and neuroma formation was seen in the static groups 
at the site of suture of the stump.  This is comparable to the response seen after 
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post-transectional nerve capping [Galeano M et al, 2009]. The animals had 
suffered extensive automutilation, presumably as a result of the neuroma 
formation [Zeltser R et al, 2000].  Neurofilament staining did not reveal the 
presence of axons nor graft cell bodies within the tubes, indicating that the static 
cultures may not have survived at this time point.  It is unclear whether the 
axonal regeneration occurred at all, or after nerve ingrowth and subsequent 
retraction.  Since the distal end of the tube was sealed, all vascularization seen 
must have originated at the proximal end of the tube.  This form of 
vascularization typically accompanies nerve regeneration [Best TJ et al, 1999], 
however, suggesting that abortive reinnervation may indeed have occurred.  The 
stretch-grown construct group showed evidence of neurite ingrowth, albeit 
sparse, and graft axon survival in those areas.  No neuromas were evident in this 
group, and automutilation was much less pronounced. 
 
Evaluation of the neural interface in vivo 
Following from these results, a commercially available flexible electrode 
array made of polyimide PI12611 was incorporated into the pre-stretch design, 
enabling the creation of a fully-formed neural-electrical interface in vitro.  
Polyimide was selected as the base material as it has been shown to be durable, 
flexible, capable of being implanted over several years, and inciting only minimal 
fibrotic response [Lago N et al, 2007; Klinge et al, 2001; Navarro et al, 1998].  
This interface was transplanted against the transected sciatic nerve, and left in 
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vivo for 4 weeks.  A gross evaluation of the neural interface upon removal 
showed that interface design is capable of withstanding normal ambulatory 
movement of the animal, at least in the acute phase.  Fibrous tissue was seen 
surrounding the collagen conduit, which paradoxically may have provided 
additional stability.  The polyimide strip, however, was surprisingly devoid of 
fibrous tissue even in this acute time frame, suggesting that it may be capable of 
withstanding host rejection within this design over a longer period. 
Careful exposure of the tube revealed a proximal stump that was now in 
the close contact with the polyimide strip.  Unlike in the previous study where 
only sparse host ingrowth was seen, here the nerve appeared to be of a much 
more robust girth.  This may be a result of the pre-coated polyimide strip 
presenting a favorable 2-dimensional regenerative surface for the nerve to grow 
along [Bellamkonda RV, 2006].  It should be noted that although the agarose gel 
kept the nerve and polyimide in close contact, manipulation of the nerve-
electrode interface revealed a weak adhesion.  This may be a result of minimal 
fibrotic infiltration due to the use of the salmon fibrin sealant – chronically 
implanted polyimide nerve cuffs maintain their neural connection only upon 
encapsulation by fibrous tissue [Rodriguez FJ et al, 2000].  It remains to be seen 
if a beneficial fibrotic response occurs after enzymatic degradation of the agarose 
and fibrin. 
Histological evaluation of the nerve-electrode contact revealed axonal 
growth in close proximity to the polyimide surface.  The separation ranged from 
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100-200µm, as demonstrated by NF200 and Tau staining.  In comparison, 
polyimide nerve cuff electrodes can consistently stimulate and record axonal 
activity at distances of up to 400µm [Naples GG et al, 1990], suggesting that the 
axon-electrode separation observed here is electrophysiologically viable.  
Finally, while the stretch-grown axons have been shown to be 
electrophysiologically functional [Pfister BJ et al, 2006], there was no evidence of 
host synaptic integration with either of the graft cell body populations.  Although 
the design goal of this project was simply to coax axonal growth into the vicinity 
of the electrode substrate, such synaptic integration could also provide a 
mechanism for stable neuro-electrical interfacing over the long-term, and thus 
warrants further investigation. 
 
5.5 SUMMARY OF FINDINGS: 
 
Conclusions 
In the absence of the appropriate distal target with which to integrate, 
regenerating axons will retract and sprout numerous collateral branches that then 
either inaccurately innervate surrounding tissue or coalesce into a neuroma at 
the site.  Here, we demonstrate a method of extending and maintaining these 
axons for at least 4 weeks with retraction, despite the absence of an end target, 
using living stretch-grown axonal tracts.  We then harnessed this phenomenon to 
  91 
entice host neurite growth into close contact with an implanted electrode 
substrate, potentially enabling recording and/or stimulation from these fascicles. 
host axonal growth into close contact with an implanted electrode substrate.  
While our findings are preliminary, they represent an important initial step in 
evaluating the feasibility of this novel bio-electrical hybrid platform for long-term 
interfacing with the peripheral nervous system.  
 
Limitations and Future Studies  
The principal limitations of this study are two-fold.  First, while the findings 
are suggestive of the advantages offered by stretch-grown axons, a clearer 
understanding can only be reached by using a larger sample size per group.  In 
particular, a quantification of the number of axon fibers in the vicinity of the 
electrode will enable us to determine critical design characteristics and sensitivity 
of the electrodes themselves.   
The second important limitation is the acute time point – while the 4-week 
time point was selected in order to understand and solve the short-term design 
challenges, a thorough understanding of the benefits of this approach can only 
be reached after several months of implantation.  It is vital to determine whether 
the axons can be maintained in proximity to the array for months to years, as well 
as if they demonstrate signs of continued development, such as fasciculation and 
myelination, which are essential for robust electrophysiological function.  Based 
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on our results, we believe that a comprehensive histological assessment of the 
neural interface at 6 months and 1 year in vivo is merited. 
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Chapter 6:  Synthesis and Future Work 
 
6.1 Introduction 
Peripheral nerve damage following trauma can often be a debilitating 
condition resulting in pain and disability for prolonged periods.  In its most severe 
form, the entire nerve trunk is transected resulting in complete discontinuity and a 
total loss of function without surgical intervention.  If the distal stump is still 
present, bridging techniques using nerve guidance channels can be employed; 
however, if the injury is too extensive or too proximally located, the prognosis is 
invariably poor.  If a distal pathway is absent, as in the case of a limb amputation, 
the nerve will either aberrantly innervate surrounding tissue or form a neuroma at 
the site.  Without a suitable means to chronically record intent-related activity 
from the nerve, it essentially becomes extraneous. 
The purpose of this study was to evaluate the ability of transplantable 
nervous tissue constructs to augment natural regeneration of transected 
peripheral nerves in order to (1) enable repair of a short lesion at both the 
proximal and distal ends, and (2) facilitate extensive and maintenance of the 
axons in the absence of a distal target, with the ultimate goal of creating a bi-
directional neural interface with the PNS.   
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6.2 Summary and Synthesis of Major Findings 
  
 The first major goal in this project was to create a stable and reproducible 
encapsulation methodology for the axonal constructs.  Previous collagen gel-
based encapsulation schemes provided minimal physical support for the axonal 
constructs, resulting in frequent disruption of the tracts during removal from the 
culture environment.  The stretch-growth protocol was modified to incorporate 
agarose hydrogel as the base layer upon which cell bodies were plated, and the 
optimal parameters for neurite outgrowth and tissue encapsulation were 
determined.  Finally, salmon fibrin was incorporated as an end sealant at the time 
of implantation, in order to attenuate macrophage and glial infiltration as well as 
provide additional stability at the site of the suture.  The salmon fibrin appeared 
to have contributed to the slow disintegration of the agarose over the initial 4 
weeks, although this disintegration was complete within 8 weeks.  Since allograft 
tissue is employed in these studies, the benefit provided by the fibrin in 
preventing macrophage infiltration outweighs the short-term drawbacks, and as 
such it will continue to be incorporated into the transplantation design. 
 Stretch-grown axonal constructs appeared to offer a clear benefit over 
static neural populations in repairing short PNS lesions.  This benefit was most 
apparent during electrophysiological evaluation, where a statistically significant 
difference in the conduction velocity ratios was observed.  This appeared to 
correlate with the extent of regeneration seen within the graft tubes; the axonal 
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construct group appeared to demonstrate robust neural and vascular growth 
through the tube, whereas growth was limited to along the walls in the static 
group.  This suggests that regenerating neurites, and their accompanying 
vasculature, preferentially proceed along aligned axonal pathways, in a process 
approximating naturally occurring axon-mediated axon growth.  The neural cell 
bodies themselves, which are entirely absent in the periphery, may simply be 
indiscernible to the host axons and thus provide no therapeutic benefit. 
On the other hand, these cell bodies – and, more specifically, the neurites 
emanating from them – seem to play a significant role in maintaining the distal 
pathway far longer than naturally possible.  The morphology of the distal stump 
at 4 months resembled that of control nerves at 2 weeks, thus potentially 
increasing the time window within which successful reinnervation may occur.  
The absence of any surviving neurites and cell bodies suggests, however, that 
this protective effect is transient.  In the vast majority of cases, reinnervation of 
the distal pathway will have occurred within this timeframe.  However, for very 
extensive lesions this delay may itself not be sufficient.  The use of immune 
suppressants may be able to prolong the eventual atrophy of the grafted cells, 
and would be an important future area of study. 
Stretch-grown axons were also shown to enable host axons regeneration 
and maintenance for 4 weeks without the presentation of any distal target.  This 
runs contrary to conventional dogma, wherein regenerating neurites will retract 
and attempt collateral branching in the continued pursuit of a target.  Excessive 
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collateral branching often leads to neuroma formation – indeed, this was 
uniformly observed in static culture group.  The mechanisms by which the axonal 
constructs enable this axonal maintenance is unclear, as is the temporal limits if 
any.  However, we did observe that incorporating an electrode substrate into the 
design enabled host axonal growth into its vicinity.  The extent of host infiltration 
as well as the long-term behavior of these axons will need to be quantified in 
order for this neural-interface platform to be feasible.  However, the short-term 
results obtained thus far merit a more comprehensive investigation of this 
architecture. 
 
6.3 Future Work 
The preceding studies described a novel method of repairing nerve lesion, 
and potentially interfacing with the peripheral nervous system, using engineered 
living nervous tissue.  However, several areas warrant further study which should 
be considered for future investigations.   
 
Developing transplantable axon tracts 
 Currently the axonal tracts generated are planar in nature – this is 
particularly disadvantageous during removal from culture environment for nerve 
repair applications, where the tracts need to be compressed into a narrow tube in 
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order to achieve a reasonable axon density.  An important solution to this would 
be to create 3-dimensional axonal tracts that conform to the dimensions of the 
nerve guidance channels.  We are evaluating the use of various hydrogels as the 
embedding matrix, and will modify the stretch-growth chambers to incorporate 
these structures. 
 
Repair of PNS lesions 
A more thorough understanding of the precise benefit offered by the 
stretch-grown axons is needed.  While methods such as electrophysiology are 
immensely informative, it would be useful to correlate this information with a 
more quantitative assessment of the regeneration, including axonal density, 
myelination, etc.  In addition, earlier (less than 2 weeks) and later (greater than 4 
months) time points would be useful in determining the rate of regeneration and 
then extent and nature of reinnervation (motor versus sensory). A clearer 
understanding is also needed of the mechanisms by which axonal constructs 
augment host axonal regeneration.  It would be important to isolate those 
components (chemotaxic and/or haptotaxic) that especially influence 
regeneration.  By doing so, we may be able to create artificial conduits 
incorporating these elements, thus eliminating the need for living tissue 
transplantation. 
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 For distal degeneration, it is important to determine the mechanism by 
which the constructs provided pathway maintenance, as well as the reasons for 
their eventual degradation.  Evaluation at an earlier time point would be useful in 
determining the lifespan of the constructs.  Finally, the use of immune 
suppressants or other agents as a means of prolonging their survival would be 
important to determine. 
 
Development of a neural interface 
 A clearer quantitative understanding of the extent and nature of the 
regenerating axons is critical in determining the viability of this neural interface 
platform.  While axon retraction and neuroma formation were not observed in the 
acute phase, this must be verified over the long-term.  An evaluation of the host 
axon density and myelination must also be performed in order to determine the 
appropriate electrical characteristics of the electrodes.  Finally, an improved 
integrated electrode design needs to be developed.  Although we are merely 
evaluating the feasibility of this approach using a variety of commercially 
available components, none of them have been developed for this application.  A 
more appropriate neural-interface design would incorporate a multi-channel 
electrode substrate encapsulating a 3-dimensional nervous tissue construct.  
Such a design would allow for more robust host innervation, and potentially 
enable selective stimulation and recording from individual fascicles. 
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6.4 Conclusion 
 In summary, this thesis demonstrates the feasibility of using engineered 
nervous tissue constructs in the repair of peripheral nerve lesions and 
amputations.  While this is only a preliminary analysis, further development of 
these techniques may result in clinically applicable therapeutic strategies for 
extensive nervous system repair. 
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